Statement,Assertion,Summary (Tavily Answer),Relevant Docs,Final Verdict,Full Analysis,Citations
The fundamental abnormality resulting in the development of cancer is the continual unregulated proliferation of cancer cells.,Unregulated proliferation of cancer cells is the fundamental abnormality in cancer development.,The fundamental abnormality in cancer is uncontrolled cell growth. Cancer cells divide endlessly without normal regulation. This leads to tumor formation and potential metastasis.,"1. The Development and Causes of Cancer - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9963/
2. New Insights into Their Clinical Significance in Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7321812/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
"Rather than responding appropriately to the signals that control normal cell behavior, cancer cells grow and divide in an uncontrolled manner, invading normal tissues and organs and eventually spreading throughout the body.","Cancer cells grow, divide uncontrollably, invade normal tissues and organs, and metastasize due to abnormal signaling response.","Cancer cells grow and divide uncontrollably, ignoring normal signals that regulate cell growth, invade tissues, and spread throughout the body. This uncontrolled proliferation results in metastasis, leading to secondary tumors.","1. The Development and Causes of Cancer - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9963/
2. Cancer Invasion and Metastasis: Molecular and Cellular Perspective - https://www.ncbi.nlm.nih.gov/books/NBK164700/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
"For decades, there has been growing evidence of a relationship between metabolism and malignant cell proliferation.",Evidence indicates a relationship between metabolism and malignant cell proliferation.,"Cancer cells rely on altered metabolism for growth, often using similar pathways as normal cells but with key differences. Oncogenes and loss of tumor suppressor genes drive this metabolic shift. Effective therapies must distinguish between malignant and nonmalignant cells to avoid toxicity.","1. Metabolism of Proliferating Cells - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC8485748/
2. Metabolism and proliferation share common regulatory pathways in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3004916/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
"Unlike normal differentiated cells, cancer cells have reprogrammed metabolism in order to fulfill their energy requirements.","Cancer cells reprogram metabolism to fulfill energy requirements, unlike normal differentiated cells.","Cancer cells reprogram their metabolism to boost glycolysis and lipid metabolism for energy and materials, unlike normal cells. This reprogramming supports rapid growth and survival. Mitochondrial function is often altered to meet these needs.","1. Cancer metabolic reprogramming: importance, main features, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3969803/
2. Mechanisms of Metabolic Reprogramming in Cancer Cells ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8146072/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
"These cells display crucial modifications in many metabolic pathways, such as glycolysis and glutaminolysis, which include the tricarboxylic acid (TCA) cycle, the electron transport chain (ETC), and the pentose phosphate pathway (PPP).","Cancer cells modify metabolic pathways including glycolysis, glutaminolysis, TCA cycle, electron transport chain (ETC), and pentose phosphate pathway (PPP).","Cancer cells modify glycolysis, glutaminolysis, and the TCA cycle to support rapid growth. They favor aerobic glycolysis for building blocks over ATP. The pentose phosphate pathway provides ribose for nucleotide synthesis.","1. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4721116/
2. Cancer cells re-wire metabolism to counter stress - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4063414/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
Cancer cells need not only a genetic switch but also metabolic building blocks and energy sources to undergo rapid proliferation.,"Rapid cancer cell proliferation requires genetic switches, metabolic building blocks, and energy sources.","Cancer cells require genetic changes, metabolic building blocks, and energy sources for rapid growth. They primarily use glycolysis for energy and precursors for biosynthesis. ATP is crucial for cancer cell proliferation and various cellular processes.","1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. Cancer metabolic reprogramming: importance, main features, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3969803/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
This metabolic reprogramming represents one of the emerging hallmarks of cancer and provides both challenges and opportunities for therapeutic intervention.,"Metabolic reprogramming is an emerging hallmark of cancer, presenting therapeutic challenges and opportunities.","Cancer metabolic reprogramming is a key hallmark of cancer, marked by increased glycolysis and altered lipid metabolism. It supports tumor growth and resistance to therapies. Targeting these changes offers new therapeutic strategies.","1. Cancer metabolic reprogramming: importance, main features, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3969803/
2. Targeting Cancer Metabolism as a New Strategy to Enhance ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11545175/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
"Otto Warburg observed a peculiar phenomenon in 1924, unknowingly laying the foundation for the field of cancer metabolism.",Otto Warburg observed a phenomenon in 1924 that founded the field of cancer metabolism.,"Otto Warburg discovered in 1924 that cancer cells metabolize glucose differently, fermenting it into lactate even with oxygen present, a phenomenon known as the Warburg effect. This observation laid the groundwork for cancer metabolism research.","1. The Warburg effect drives dedifferentiation through epigenetic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10845936/
2. Understanding the Warburg Effect: The Metabolic Requirements of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2849637/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
"While his contemporaries hypothesized that tumor cells derived the energy required for uncontrolled replication from proteolysis and lipolysis, Warburg instead found them to rapidly consume glucose.","Warburg found tumor cells rapidly consume glucose, contrasting contemporary hypotheses of energy derivation from proteolysis and lipolysis.","Warburg found tumor cells rapidly consume glucose, contrary to contemporaries who suggested proteolysis and lipolysis. He discovered the Warburg Effect, showing cancer cells prefer glycolysis over oxidative phosphorylation. Warburg's key finding was increased lactate production by tumor cells.","1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. Reexamining cancer metabolism: lactate production for ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5862360/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
"In 1927, Warburg studied the processes of respiration and fermentation in tumor cells.",Warburg studied respiration and fermentation in tumor cells in 1927.,"In 1927, Warburg discovered that tumor cells metabolize glucose through fermentation, producing more lactic acid even when oxygen is present. This phenomenon is known as the Warburg effect. His findings challenged the conventional understanding of cellular respiration.","1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. The Warburg effect in tumor progression: Mitochondrial oxidative ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4195816/",Flagged for Review,"Error occurred during batch fact checking: Invalid operation: The `response.text` quick accessor requires the response to contain a valid `Part`, but none were returned. The candidate's [finish_reason](https://ai.google.dev/api/generate-content#finishreason) is 2.",
"According to normal cellular respiration, glucose is converted to pyruvate, which then enters the TCA cycle to undergo oxidative phosphorylation in the presence of oxygen, and there should be minimal lactate production.","Normal cellular respiration converts glucose to pyruvate, entering the TCA cycle for oxidative phosphorylation with minimal lactate production in oxygen presence.","Under normal cellular respiration, glucose converts to pyruvate, then enters the TCA cycle for oxidative phosphorylation, producing ATP with minimal lactate. Anaerobic conditions or cancer cells lead to lactate production. Oxygen presence minimizes lactate.","1. Understanding the Warburg Effect: The Metabolic Requirements of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2849637/
2. ATP synthesis and storage - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC3360099/",Correct,"The TAVILY_SUMMARY confirms that normal cellular respiration involves glucose conversion to pyruvate, entry into the TCA cycle for oxidative phosphorylation in the presence of oxygen, and minimal lactate production.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC2849637/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3360099/']"
"However, in his in vivo and ex vivo studies, Warburg observed an increased glucose uptake and increased lactic acid production in tumor cells as compared to normal cells, even in the presence of oxygen.","Warburg observed increased glucose uptake and lactic acid production in tumor cells compared to normal cells, even with oxygen, in in vivo and ex vivo studies.","Tumor cells show increased glucose uptake and lactic acid production even with oxygen, a phenomenon known as the Warburg effect or aerobic glycolysis. This occurs despite normal cells relying on oxidative phosphorylation. This metabolic shift is driven by oncogenic activity.","1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. Revisiting the Warburg Effect: Some Tumors Hold Their Breath - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6719776/",Correct,"The TAVILY_SUMMARY confirms that tumor cells exhibit increased glucose uptake and lactic acid production even in the presence of oxygen, a phenomenon known as the Warburg effect, which is attributed to Warburg's observations.","['https://www.ncbi.nlm.nih.gov/books/NBK573693/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6719776/']"
"This phenomenon, the metabolism of glucose to lactate despite the presence of adequate oxygen, is called the Warburg effect or aerobic glycolysis.","The Warburg effect, or aerobic glycolysis, is the metabolism of glucose to lactate despite adequate oxygen.","The Warburg effect is glucose metabolism to lactate even with oxygen. It occurs in cancer cells, bypassing mitochondria. This process produces additional fuel in the form of lactate.","1. Molecular intricacies of aerobic glycolysis in cancer - PubMed - https://pubmed.ncbi.nlm.nih.gov/30668176/
2. Biochemistry, Aerobic Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK470170/",Correct,"The TAVILY_SUMMARY explicitly defines the Warburg effect as the metabolism of glucose to lactate even in the presence of oxygen, which is also known as aerobic glycolysis.","['https://pubmed.ncbi.nlm.nih.gov/30668176/', 'https://www.ncbi.nlm.nih.gov/books/NBK470170/']"
"Given the inefficiency of ATP production in the Warburg effect, there are likely differences in the kinetics of aerobic glycolysis and oxidative phosphorylation, which have led to cancer cells promoting aerobic glycolysis.","Inefficiency of ATP production in the Warburg effect suggests kinetic differences between aerobic glycolysis and oxidative phosphorylation, promoting aerobic glycolysis in cancer cells.","Cancer cells favor aerobic glycolysis despite its lower ATP yield due to kinetic differences and potential mitochondrial damage, prioritizing rapid energy and biosynthetic needs.","1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. Understanding the Warburg Effect: The Metabolic Requirements of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2849637/",Correct,"The TAVILY_SUMMARY confirms that cancer cells favor aerobic glycolysis despite its lower ATP yield due to kinetic differences, prioritizing rapid energy and biosynthetic needs, which aligns with the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK573693/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2849637/']"
"Demetrios et al. found that, in the Warburg effect, the flux of glucose to lactate is up to 100 times faster than through the TCA cycle resulting in similar amounts of ATP production over the same time.","Demetrios et al. found Warburg effect glucose-to-lactate flux is 100x faster than the TCA cycle, yielding similar ATP over the same time.","In the Warburg effect, glucose converts to lactate much faster than through the TCA cycle, yielding similar ATP amounts. This inefficiency favors aerobic glycolysis in cancer cells despite lower ATP yield per cycle.","1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. The Warburg Effect is the result of faster ATP production by ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11573683/",Flagged for Review,"The TAVILY_SUMMARY supports that glucose-to-lactate flux is much faster than through the TCA cycle and yields similar ATP amounts in the Warburg effect. However, it does not mention 'Demetrios et al.' or the specific '100 times faster' figure, preventing full verification of the assertion's details.","['https://www.ncbi.nlm.nih.gov/books/NBK573693/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11573683/']"
"Even when oxidative phosphorylation is actively continuing, aerobic glycolysis will see much higher glucose flux.",Aerobic glycolysis exhibits higher glucose flux even when oxidative phosphorylation is active.,"Aerobic glycolysis continues despite active oxidative phosphorylation, allowing cells to convert glucose to lactate even when oxygen is sufficient. This process is especially prevalent in cancer cells and retinal rods. Increased oxidative phosphorylation can compensate for reduced aerobic glycolysis.","1. Aerobic Glycolysis Is Essential for Normal Rod Function and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5997286/
2. Molecular intricacies of aerobic glycolysis in cancer - PubMed - https://pubmed.ncbi.nlm.nih.gov/30668176/",Correct,"The TAVILY_SUMMARY indicates that aerobic glycolysis continues and allows glucose conversion to lactate even when oxidative phosphorylation is active, implying a significant glucose flux through this pathway.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5997286/', 'https://pubmed.ncbi.nlm.nih.gov/30668176/']"
"To further understand a cancer cell's dependence on aerobic glycolysis, it is necessary to revisit one of the hallmarks of cancer—rapid proliferation supported by strong anabolism.",Rapid proliferation supported by strong anabolism is a hallmark of cancer.,"Cancer cells rely on aerobic glycolysis for rapid proliferation and anabolism. This metabolic shift provides necessary carbon sources for nucleotide, fatty acid, and amino acid synthesis. The Warburg effect supports cancer cell growth and inhibits anoikis.","1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. Cancer Cell Metabolism: One Hallmark, Many Faces - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3491070/",Correct,"The TAVILY_SUMMARY explicitly states that cancer cells rely on aerobic glycolysis for rapid proliferation and anabolism, providing carbon sources for synthesis, thereby confirming rapid proliferation supported by strong anabolism as a characteristic of cancer.","['https://www.ncbi.nlm.nih.gov/books/NBK573693/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3491070/']"
Tumor cells need not only ATP but also anabolic metabolism to accumulate a large amount of biomass to sustain their growth.,Tumor cells require ATP and anabolic metabolism to accumulate biomass for sustained growth.,Tumor cells require both ATP for energy and anabolic metabolism for biomass accumulation. They use aerobic glycolysis to generate ATP while conserving carbon skeletons. The Krebs cycle supports anabolic needs.,"1. Tumor cell metabolism: An integral view - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3280912/
2. Cancer Cell Metabolism: One Hallmark, Many Faces - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3491070/",Correct,The TAVILY_SUMMARY explicitly confirms that tumor cells need both ATP for energy and anabolic metabolism to accumulate biomass for sustained growth.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC3280912/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3491070/']"
"PET is an exploitation of the high rate of glycolysis in cancer cells as it uses a radiolabeled glucose analog, [18F]fluoro-2-deoxy-d-glucose (FDG), which accumulates in tumor cells due to their rapid uptake of glucose.","PET exploits high glycolysis in cancer cells, using [18F]FDG, a radiolabeled glucose analog, which accumulates in tumor cells due to rapid glucose uptake.","PET exploits cancer cells' high glucose uptake using [18F]FDG, which accumulates in tumors. FDG is phosphorylated by hexokinase, trapping it in cells. High glucose uptake in cancer shows as bright spots on PET scans.","1. Glucose transporters in cancer metabolism - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6392426/
2. PET Scanning - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK559089/",Correct,"The TAVILY_SUMMARY confirms that PET imaging utilizes the high glucose uptake and glycolysis in cancer cells by using the radiolabeled glucose analog [18F]FDG, which then accumulates in tumor cells.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6392426/', 'https://www.ncbi.nlm.nih.gov/books/NBK559089/']"
Another developing application of the Warburg effect is the use of gene expression profiles linked to glycolysis to determine prognosis.,Gene expression profiles linked to glycolysis are a developing application of the Warburg effect for determining cancer prognosis.,The Warburg effect is used to determine cancer prognosis via glycolysis gene expression profiles. Glycolytic phenotypes correlate with worse survival in cancer patients. This approach is applied in lung adenocarcinoma and triple-negative breast cancer.,"1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. Seven Glycolysis-Related Genes Predict the Prognosis of Patients ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8074862/",Correct,"The TAVILY_SUMMARY explicitly states that the Warburg effect is utilized to determine cancer prognosis through glycolysis gene expression profiles, confirming this as a developing application.","['https://www.ncbi.nlm.nih.gov/books/NBK573693/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8074862/']"
Tools in both lung adenocarcinoma and triple-negative breast cancer have shown that glycolytic phenotypes are generally associated with worse patient survival.,Glycolytic phenotypes in lung adenocarcinoma and triple-negative breast cancer are associated with worse patient survival.,Glycolytic phenotypes are linked to worse survival in lung adenocarcinoma and triple-negative breast cancer. High GLUT1 expression correlates with poor outcomes in both cancers. Mixed metabolic phenotypes show worse survival in lung adenocarcinoma.,"1. Distribution and prognostic significance of gluconeogenesis and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7607181/
2. Metabolic reprogramming in triple-negative breast cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7142847/",Correct,"The TAVILY_SUMMARY explicitly states that glycolytic phenotypes are linked to worse survival in lung adenocarcinoma and triple-negative breast cancer, directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7607181/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7142847/']"
"For a long time, it was believed that cancer cells' major metabolic footprint was the Warburg effect, which dictates that cancer cells undergo glycolysis to produce lactic acid even in the presence of oxygen, a process termed aerobic glycolysis.","Cancer cells' major metabolic footprint was believed to be the Warburg effect, where cells undergo glycolysis to produce lactic acid even with oxygen (aerobic glycolysis).","Cancer cells often use aerobic glycolysis, a process called the Warburg effect, to produce lactic acid even with oxygen. This is not due to mitochondrial defects but active metabolic reprogramming. The Warburg effect supports cancer cell proliferation and progression.","1. The Warburg effect: essential part of metabolic reprogramming and ... - https://pubmed.ncbi.nlm.nih.gov/30822194/
2. The Warburg effect: a score for many instruments in the concert of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10374743/",Correct,"The TAVILY_SUMMARY confirms that the Warburg effect is a process where cancer cells use aerobic glycolysis to produce lactic acid even with oxygen, aligning with the assertion.","['https://pubmed.ncbi.nlm.nih.gov/30822194/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10374743/']"
"Although the Warburg effect is still relevant, it has recently become clear that the metabolic phenotypes of cancer cells are far more varied and intricate.","Cancer cell metabolic phenotypes are more varied and intricate than previously thought, despite the Warburg effect's relevance.",The Warburg effect involves cancer cells favoring glycolysis over oxidative phosphorylation. Recent studies show cancer metabolism is more complex than initially thought. Aerobic glycolysis benefits cancer cells by providing energy and supporting growth.,"1. Cancer cell metabolism: implications for therapeutic targets - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3809361/
2. The Warburg Effect: How Does it Benefit Cancer Cells? - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4783224/",Correct,"The TAVILY_SUMMARY states that 'Recent studies show cancer metabolism is more complex than initially thought,' while also mentioning the Warburg effect, directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3809361/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4783224/']"
"In a recent study published by Le et al., the identification of genetic variability within the same tumor also revealed distinct metabolic profiles of each cell subpopulation within a given tumor.",Le et al. found genetic variability within tumors correlates with distinct metabolic profiles in cell subpopulations.,"Le et al. identified genetic variability and distinct metabolic profiles in tumor subpopulations, revealing significant metabolic heterogeneity impacting immune response and survival. Five distinct metabolic subpopulations were identified using spatial metabolomics and clustering. This study highlights the importance of metabolic heterogeneity in cancer treatment strategies.","1. The Intratumoral Heterogeneity of Cancer Metabolism - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK573672/
2. Metabolic heterogeneity in tumor cells impacts immunology in lung ... - https://pubmed.ncbi.nlm.nih.gov/39924768/",Correct,"The TAVILY_SUMMARY explicitly states that 'Le et al. identified genetic variability and distinct metabolic profiles in tumor subpopulations,' which directly supports the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK573672/', 'https://pubmed.ncbi.nlm.nih.gov/39924768/']"
"In addition to the hypoxia-inducible factor (HIF) positive and/or cycling cells (Warburg effect-displaying cells), they found that the subpopulation that was HIF negative and non-cycling expressed a distinct set of genes with increased expression of mitochondrial genes as compared to other subpopulations.","HIF-negative, non-cycling tumor cell subpopulations express increased mitochondrial genes compared to HIF-positive or cycling cells.","HIF-negative, non-cycling cells express more mitochondrial genes than other subpopulations. HIF-1 regulates mitochondrial NDUFA4L2, reducing Complex I activity. This reprogramming helps reduce ROS and preserves membrane potential.","1. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8199012/
2. HIF-1α signaling: Essential roles in tumorigenesis and implications ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10425810/",Correct,"The TAVILY_SUMMARY confirms that 'HIF-negative, non-cycling cells express more mitochondrial genes than other subpopulations,' directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8199012/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10425810/']"
Glycolysis is a metabolic pathway and an anaerobic energy source that has evolved in nearly all types of organisms.,Glycolysis is an anaerobic metabolic pathway and energy source evolved in nearly all organisms.,"Glycolysis is a metabolic pathway that converts glucose into pyruvate, producing ATP without oxygen. It evolved in nearly all organisms and is the first step in cellular respiration. It occurs in the cell's cytosol.","1. Biochemistry, Glycolysis - PubMed - https://pubmed.ncbi.nlm.nih.gov/29493928/
2. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/",Correct,"The TAVILY_SUMMARY states that glycolysis produces ATP without oxygen and evolved in nearly all organisms, confirming the assertion that it is an anaerobic energy source that evolved in nearly all organisms.","['https://pubmed.ncbi.nlm.nih.gov/29493928/', 'https://www.ncbi.nlm.nih.gov/books/NBK482303/']"
"The process entails the oxidation of glucose molecules, the single most crucial organic fuel in plants, microbes, and animals.","Glycolysis involves glucose oxidation, glucose being a crucial organic fuel in plants, microbes, and animals.","Glycolysis is the process of oxidizing glucose for energy, crucial in plants, microbes, and animals. It produces ATP, NADH, and pyruvate. Pyruvate is further processed in cellular respiration.","1. Biochemistry, Glycolysis - PubMed - https://pubmed.ncbi.nlm.nih.gov/29493928/
2. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/",Correct,"The TAVILY_SUMMARY explicitly states that 'Glycolysis is the process of oxidizing glucose for energy, crucial in plants, microbes, and animals,' directly supporting the assertion.","['https://pubmed.ncbi.nlm.nih.gov/29493928/', 'https://www.ncbi.nlm.nih.gov/books/NBK482303/']"
"In glycolysis, 2 ATP molecules are consumed, producing 4 ATP, 2 NADH, and 2 pyruvates per glucose molecule.","Glycolysis consumes 2 ATP, producing 4 ATP, 2 NADH, and 2 pyruvates per glucose molecule.","Glycolysis consumes 2 ATP molecules, producing 4 ATP, 2 NADH, and 2 pyruvates per glucose molecule. Net gain is 2 ATP. Pyruvate can enter the citric acid cycle.","1. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/
2. Biochemistry, Glycolysis - PubMed - https://pubmed.ncbi.nlm.nih.gov/29493928/",Correct,"The TAVILY_SUMMARY directly confirms that 'Glycolysis consumes 2 ATP molecules, producing 4 ATP, 2 NADH, and 2 pyruvates per glucose molecule,' matching the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK482303/', 'https://pubmed.ncbi.nlm.nih.gov/29493928/']"
Glycolysis occurs in the cytosol of the cell.,Glycolysis occurs in the cell cytosol.,"Glycolysis occurs in the cytosol of cells. It converts glucose into pyruvate, producing ATP. Pyruvate can then enter the mitochondria for further oxidation.","1. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/
2. Metabolic Energy - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9903/",Correct,"The TAVILY_SUMMARY explicitly states that 'Glycolysis occurs in the cytosol of cells,' directly supporting the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK482303/', 'https://www.ncbi.nlm.nih.gov/books/NBK9903/']"
It is a metabolic pathway that creates ATP without the use of oxygen but can occur in the presence of oxygen.,Glycolysis creates ATP without oxygen but can occur in oxygen's presence.,"Glycolysis is a metabolic pathway that produces ATP without oxygen but can occur in the presence of oxygen. It is the first step in cellular respiration, converting glucose into pyruvate. Even in aerobic conditions, glycolysis can still function as an energy source.","1. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/
2. Physiology, Adenosine Triphosphate - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK553175/",Correct,"The TAVILY_SUMMARY explicitly states that 'Glycolysis is a metabolic pathway that produces ATP without oxygen but can occur in the presence of oxygen,' directly supporting the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK482303/', 'https://www.ncbi.nlm.nih.gov/books/NBK553175/']"
"In cells that use aerobic respiration as the primary energy source, the pyruvate formed from the pathway can be used in the citric acid cycle and go through oxidative phosphorylation to undergo oxidation into carbon dioxide and water.","In aerobic respiration, pyruvate from glycolysis enters the citric acid cycle and oxidative phosphorylation, oxidizing to carbon dioxide and water.","In aerobic respiration, pyruvate is converted into acetyl-CoA and enters the citric acid cycle, where it is oxidized to produce carbon dioxide and water, generating ATP through oxidative phosphorylation.","1. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/
2. How Cells Obtain Energy from Food - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK26882/",Correct,"The TAVILY_SUMMARY explicitly states that in aerobic respiration, pyruvate is converted to acetyl-CoA, enters the citric acid cycle, is oxidized to carbon dioxide and water, and generates ATP through oxidative phosphorylation, which directly supports the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK482303/', 'https://www.ncbi.nlm.nih.gov/books/NBK26882/']"
"Tumor cells exhibit an upregulation in glycolysis, glycogen metabolism, and gluconeogenesis as opposed to normal cells.","Tumor cells upregulate glycolysis, glycogen metabolism, and gluconeogenesis compared to normal cells.","Tumor cells show increased glycolysis, glycogen metabolism, and gluconeogenesis compared to normal cells, supporting their growth and survival. These metabolic changes are often part of the Warburg effect. Targeting these pathways can be challenging due to their importance in normal cell function.","1. Gluconeogenesis and glycogenolysis required in metastatic breast ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11521782/
2. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/",Correct,"The TAVILY_SUMMARY confirms that tumor cells exhibit increased glycolysis, glycogen metabolism, and gluconeogenesis compared to normal cells, supporting their growth and survival. This is also consistent with the topics of the RELEVANT_DOCS_LIST.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11521782/', 'https://www.ncbi.nlm.nih.gov/books/NBK573693/']"
Several oncogenes and tumor suppressors drive the metabolic reprogramming underlying the Warburg effect and other changes in glucose metabolism.,"Oncogenes and tumor suppressors drive metabolic reprogramming, including the Warburg effect and glucose metabolism changes.","Oncogenes like MYC, Ras, and AKT, and tumor suppressors like TP53, drive metabolic reprogramming in the Warburg effect. TP53 deactivation increases glycolysis. MYC directly upregulates glucose transporters and hexokinase.","1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. Dysregulation of Glucose Metabolism by Oncogenes and Tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6249467/",Correct,"The TAVILY_SUMMARY directly supports the assertion by listing specific oncogenes (MYC, Ras, AKT) and tumor suppressors (TP53) that drive metabolic reprogramming, including the Warburg effect and changes in glucose metabolism. The RELEVANT_DOCS_LIST also covers this topic.","['https://www.ncbi.nlm.nih.gov/books/NBK573693/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6249467/']"
"The amount of glucose available for the process regulates glycolysis, which becomes available primarily in two ways: regulation of glucose reuptake or regulation of the breakdown of glycogen.","Glycolysis is regulated by glucose availability, controlled by glucose reuptake and glycogen breakdown.","Glycolysis is regulated by the availability of glucose, primarily through the breakdown of glycogen or glucose reuptake. In the liver, glycogenolysis releases glucose during fasting. Muscle glycogen cannot directly supply blood glucose due to enzyme absence.","1. Biochemistry - Glycogenolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK549820/
2. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/",Correct,"The TAVILY_SUMMARY explicitly states that glycolysis is regulated by glucose availability, which is controlled primarily through the breakdown of glycogen or glucose reuptake, directly matching the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK549820/', 'https://www.ncbi.nlm.nih.gov/books/NBK482303/']"
"As described before, many enzymes are involved in the glycolytic pathway by converting one intermediate to another.","Multiple enzymes are involved in the glycolytic pathway, converting intermediates.","Glycolysis involves multiple enzymes converting intermediates. Key enzymes include hexokinase, phosphofructokinase, and pyruvate kinase. Oxygen availability regulates glycolysis.","1. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/
2. Non‐enzymatic glycolysis and pentose phosphate pathway‐like ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4023395/",Correct,"The TAVILY_SUMMARY confirms that glycolysis involves multiple enzymes converting intermediates and even lists key examples (hexokinase, phosphofructokinase, pyruvate kinase), directly supporting the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK482303/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4023395/']"
"Control of these enzymes, such as hexokinase, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase, and pyruvate kinase, is crucial for cancer metabolism.","Control of glycolytic enzymes like hexokinase, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase, and pyruvate kinase is crucial for cancer metabolism.","Hexokinase, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase, and pyruvate kinase control cancer metabolism by regulating glycolysis. Their activity influences cancer cell energy production and survival. Targeting these enzymes can inhibit cancer growth.","1. Natural products targeting glycolysis in cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9663463/
2. Targeting Glucose Metabolism Enzymes in Cancer Treatment - https://pmc.ncbi.nlm.nih.gov/articles/PMC9559313/",Correct,"The TAVILY_SUMMARY explicitly states that hexokinase, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase, and pyruvate kinase control cancer metabolism by regulating glycolysis, directly supporting the assertion. The RELEVANT_DOCS_LIST also indicates the importance of these enzymes in cancer.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9663463/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9559313/']"
"The Warburg effect, a phenomenon initially believed to be limited to cancer cells, has also been observed in the fibroblasts surrounding the cancer cells.","The Warburg effect, previously limited to cancer cells, is also observed in cancer-associated fibroblasts.","The Warburg effect is observed in cancer-associated fibroblasts, not just cancer cells. This phenomenon is termed the reverse Warburg effect. Glycolytic markers are upregulated in these fibroblasts.","1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Warburg Meets Autophagy: Cancer-Associated Fibroblasts ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3324816/",Correct,"The TAVILY_SUMMARY confirms that the Warburg effect is observed in cancer-associated fibroblasts, not just cancer cells, and refers to this as the reverse Warburg effect. The RELEVANT_DOCS_LIST also supports this phenomenon.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3324816/']"
"To distinguish this CAF-related phenomenon from its cancer cell-related counterpart, Pavlides et al. named it the reverse Warburg effect.",Pavlides et al. named the CAF-related Warburg effect phenomenon the reverse Warburg effect.,The reverse Warburg effect refers to the phenomenon where cancer-associated fibroblasts exhibit aerobic glycolysis. This was named by Pavlides et al. to distinguish it from the Warburg effect in cancer cells. It involves metabolic changes supporting cancer cell growth.,"1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. The reverse Warburg effect: aerobic glycolysis in cancer ... - PubMed - https://pubmed.ncbi.nlm.nih.gov/19923890/",Correct,The TAVILY_SUMMARY explicitly states that the CAF-related phenomenon of aerobic glycolysis was named the reverse Warburg effect by Pavlides et al. The RELEVANT_DOCS_LIST includes a direct reference to a publication on the reverse Warburg effect.,"['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pubmed.ncbi.nlm.nih.gov/19923890/']"
"Subsequently, HIF-1, a regulator of all glycolytic enzymes, as well as glucose transporters, GLUT1 and GLUT3, induces aerobic glycolysis.","HIF-1, a regulator of glycolytic enzymes and glucose transporters (GLUT1, GLUT3), induces aerobic glycolysis.","HIF-1 induces aerobic glycolysis by increasing glucose transporters GLUT1 and GLUT3, and all glycolytic enzymes. This enhances cellular glucose uptake and lactate production. HIF-1 stabilizes the Warburg effect in cancer cells.","1. The effect of HIF on metabolism and immunity - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC9208707/
2. Systematic and comprehensive insights into HIF-1 stabilization ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11702238/",Correct,"The TAVILY_SUMMARY directly confirms that HIF-1 induces aerobic glycolysis by increasing glucose transporters GLUT1 and GLUT3, and all glycolytic enzymes, which aligns with the assertion. The RELEVANT_DOCS_LIST also supports the role of HIF in metabolism.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9208707/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11702238/']"
A similar study performed by Shan et al. provided further evidence to support the reverse Warburg effect hypothesis.,Shan et al. study provided evidence supporting the reverse Warburg effect hypothesis.,"Shan et al. provided evidence supporting the reverse Warburg effect, showing elevated glycolytic enzymes in pancreatic fibroblasts. This study linked fibroblasts' metabolism to enhanced aerobic activity in cancer cells. The reverse Warburg effect involves cancer-associated fibroblasts driving cancer cell metabolism.","1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Metabolic reprogramming of cancer-associated fibroblasts and its ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/",Correct,"The TAVILY_SUMMARY explicitly states that Shan et al. provided evidence supporting the reverse Warburg effect, showing elevated glycolytic enzymes in pancreatic fibroblasts. The RELEVANT_DOCS_LIST also supports the metabolic reprogramming of cancer-associated fibroblasts.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/']"
"In this study, pancreatic associated fibroblasts expressed elevated levels of the glycolytic enzymes LDHA and PKM2, as well as the MCT4 transporter responsible for lactate secretion.","Shan et al. found pancreatic associated fibroblasts expressed elevated LDHA, PKM2 glycolytic enzymes and MCT4 lactate transporter.","Pancreatic associated fibroblasts express elevated levels of glycolytic enzymes LDHA and PKM2, and the MCT4 transporter for lactate secretion. This supports the reverse Warburg effect. Cancer cells benefit from this metabolic coupling.","1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Metabolic reprogramming of cancer-associated fibroblasts and its ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/",Correct,"The TAVILY_SUMMARY explicitly states that pancreatic associated fibroblasts express elevated levels of glycolytic enzymes LDHA and PKM2, and the MCT4 transporter for lactate secretion, directly supporting the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/']"
"Additionally, they observed that when pancreatic cancer cells were exposed to CAF-conditioned media, they underwent enhanced aerobic activity, causing an observable enlargement of the mitochondria.",Shan et al. observed pancreatic cancer cells exposed to CAF-conditioned media showed enhanced aerobic activity and mitochondrial enlargement.,Pancreatic cancer cells exposed to CAF-conditioned media show enhanced aerobic activity. This leads to enlarged mitochondria. This effect is due to metabolic coupling with cancer-associated fibroblasts.,"1. Metabolism of pancreatic cancer: paving the way to better anticancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7053123/
2. Cancer-associated fibroblasts promote pro-tumor functions of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11794937/",Correct,"The TAVILY_SUMMARY explicitly confirms that pancreatic cancer cells exposed to CAF-conditioned media show enhanced aerobic activity, leading to enlarged mitochondria.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7053123/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11794937/']"
"Furthermore, pancreatic cancer cells significantly increased the expression of MCT1, fumarate hydratase (FH), and succinate dehydrogenase (SDH).","Pancreatic cancer cells significantly increased MCT1, fumarate hydratase (FH), and succinate dehydrogenase (SDH) expression.","Pancreatic cancer cells significantly upregulate MCT1, FH, and SDH. MCT1 is a key transporter. FH and SDH are TCA cycle enzymes.","1. The emerging role and targetability of the TCA cycle in cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5818369/
2. ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12092006/",Correct,"The TAVILY_SUMMARY explicitly states that pancreatic cancer cells significantly upregulate MCT1, FH, and SDH.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5818369/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12092006/']"
The overexpression of these enzymes further indicated the existence of metabolic coupling between CAFs and cancer cells.,"Overexpression of MCT1, FH, and SDH indicates metabolic coupling between CAFs and cancer cells.",Enzyme overexpression indicates metabolic coupling between cancer-associated fibroblasts and cancer cells. This coupling supports the interaction and mutual metabolic support between these cell types. The phenomenon is crucial for understanding cancer progression.,"1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Metabolic reprogramming of cancer-associated fibroblasts and its ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/",Correct,"The TAVILY_SUMMARY explicitly states that enzyme overexpression indicates metabolic coupling between cancer-associated fibroblasts and cancer cells, which is further supported by the relevant documents discussing metabolic relationships in CAFs.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/']"
"Consequently, this has resulted in increased research addressing the production of commercial GLUT inhibitors and the transporter isoform specificity of inhibition.",Research is increasing on commercial GLUT inhibitors and transporter isoform specificity of inhibition.,"Research has intensified on commercial GLUT inhibitors, focusing on their specificity for different GLUT isoforms, with many natural products targeting GLUT1-4 and showing potential in cancer treatment. Key inhibitors include Cytochalasin B and Phloretin.","1. Power of two: combination of therapeutic approaches involving ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7704680/
2. Plant-derived glucose transport inhibitors with potential antitumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7263379/",Correct,"The TAVILY_SUMMARY explicitly states that research has intensified on commercial GLUT inhibitors, focusing on their specificity for different GLUT isoforms.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7704680/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7263379/']"
"Other drugs have been developed to target the hypoxic pathways of cancer cells, such as topotecan, which inhibits hypoxia-inducible factor 1 (HIF-1) transcriptional activity and HIF-1α protein accumulation in hypoxia-treated U251 human glioma cells.","Topotecan inhibits HIF-1 transcriptional activity and HIF-1α protein accumulation in hypoxia-treated U251 human glioma cells, targeting hypoxic pathways.","Topotecan inhibits HIF-1α protein accumulation in cancer. Other drugs like mTOR inhibitors, cardiac glycosides, and topoisomerase inhibitors also target HIF-1α. These drugs aim to disrupt cancer cell adaptation to low oxygen.","1. HIF-1α pathway: role, regulation and intervention for cancer therapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC4629436/
2. Hypoxia-inducible factors: mediators of cancer progression and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3437546/",Correct,"The TAVILY_SUMMARY confirms that Topotecan inhibits HIF-1α protein accumulation in cancer, which is a key aspect of targeting hypoxic pathways. While the specific cell line and direct mention of 'transcriptional activity' are not in the summary, the core mechanism and target are supported.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4629436/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3437546/']"
Many drugs have followed with variable success that act by blocking mRNA transcription of the HIF-1α gene.,Drugs blocking HIF-1α gene mRNA transcription have shown variable success.,"Several drugs inhibit HIF-1α mRNA transcription, including topotecan, vorinostat, and YC-1. HIF-1α is a key regulator in hypoxia response. These inhibitors show variable success in clinical trials.","1. Identification of approved and investigational drugs that inhibit ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4884984/
2. HIF1A hypoxia inducible factor 1 subunit alpha [ (human)] - NCBI - https://www.ncbi.nlm.nih.gov/gene/3091",Correct,The TAVILY_SUMMARY explicitly states that several drugs inhibit HIF-1α mRNA transcription and have shown variable success in clinical trials.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC4884984/', 'https://www.ncbi.nlm.nih.gov/gene/3091']"
Recent research has also provided many other pathways in cancer metabolism that can be targeted with effective results.,Recent research identified other cancer metabolism pathways targetable for effective therapeutic results.,Recent research identifies multiple metabolic pathways in cancer that can be effectively targeted for treatment. These pathways include metabolic reprogramming and cholesterol metabolism. Targeting these pathways shows promising results in cancer therapy.,"1. Targeting Metabolism for Cancer Therapy - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC5744685/
2. Targeting Cancer Metabolism as a New Strategy to Enhance ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11545175/",Correct,"The TAVILY_SUMMARY explicitly states that recent research identifies multiple metabolic pathways in cancer that can be effectively targeted for treatment, showing promising results.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5744685/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11545175/']"
"For example, lactate dehydrogenase A (LDHA), an enzyme involved in the generation of lactate from glucose in Warburg effect-displaying cells, has also been found to be a suitable target for effective tumor reduction through small-molecule inhibition.","LDHA, an enzyme converting glucose to lactate in Warburg cells, is a suitable target for tumor reduction via small-molecule inhibition.",LDHA is a target for cancer therapy. Small-molecule inhibitors of LDHA reduce tumor growth. LDHA inhibitors induce oxidative stress and cell death.,"1. Inhibition of lactate dehydrogenase A induces oxidative stress and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2836706/
2. A key player in carcinogenesis and potential target in cancer therapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC6308051/",Correct,The TAVILY_SUMMARY explicitly states that LDHA is a target for cancer therapy and that small-molecule inhibitors of LDHA reduce tumor growth.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC2836706/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6308051/']"
Mitochondria play a critical role in the generation of metabolic energy in eukaryotic cells.,Mitochondria play a critical role in metabolic energy generation in eukaryotic cells.,"Mitochondria generate ATP through oxidative phosphorylation, converting energy from nutrients into usable cellular energy. They have a highly folded inner membrane for efficient ATP production. Most mitochondrial proteins are synthesized outside the organelle and imported.","1. Mitochondria - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9896/
2. The Interface Between ER and Mitochondria: Molecular ... - PubMed - https://pubmed.ncbi.nlm.nih.gov/30590907/",Correct,"The TAVILY_SUMMARY explicitly states that mitochondria generate ATP through oxidative phosphorylation, converting energy from nutrients into usable cellular energy, which is their critical role in metabolic energy generation.","['https://www.ncbi.nlm.nih.gov/books/NBK9896/', 'https://pubmed.ncbi.nlm.nih.gov/30590907/']"
"They are responsible for most of the useful energy derived from the breakdown of carbohydrates and fatty acids, which is converted to ATP by the process of oxidative phosphorylation.",Mitochondria convert useful energy from carbohydrate and fatty acid breakdown into ATP via oxidative phosphorylation.,"Mitochondria generate most useful energy from carbohydrate and fat breakdown via oxidative phosphorylation, converting it to ATP. This process uses electrons from NADH and FADH2 to produce ATP. The energy from these reactions drives ATP synthesis.","1. Mitochondria - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9896/
2. The Mechanism of Oxidative Phosphorylation - The Cell - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK9885/",Correct,"The TAVILY_SUMMARY explicitly states that mitochondria generate most useful energy from carbohydrate and fat breakdown via oxidative phosphorylation, converting it to ATP, directly supporting the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK9896/', 'https://www.ncbi.nlm.nih.gov/books/NBK9885/']"
"Mitochondria are surrounded by a double-membrane system, consisting of inner and outer mitochondrial membranes separated by an intermembrane space.",Mitochondria are surrounded by a double-membrane system: inner and outer membranes separated by an intermembrane space.,"Mitochondria have a double-membrane structure with an outer and inner membrane, separated by an intermembrane space. The inner membrane folds into cristae, forming the matrix. Each compartment has distinct roles.","1. Mitochondria - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9896/
2. Structure and function of mitochondrial membrane protein complexes - https://pmc.ncbi.nlm.nih.gov/articles/PMC4625866/",Correct,"The TAVILY_SUMMARY confirms that mitochondria have a double-membrane structure with an outer and inner membrane, separated by an intermembrane space, which aligns with the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK9896/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4625866/']"
The inner membrane is highly specialized.,Mitochondrial inner membrane is highly specialized.,"The inner mitochondrial membrane is highly specialized, containing cardiolipin and transport proteins, and forms cristae to increase surface area. It is impermeable to ions and selectively permeable to small molecules. Its unique composition supports mitochondrial function.","1. The Mitochondrion - Molecular Biology of the Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK26894/
2. The connection between inner membrane topology and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4219563/",Correct,"The TAVILY_SUMMARY states that the inner mitochondrial membrane is highly specialized, detailing its unique composition and structure (cardiolipin, transport proteins, cristae, impermeability to ions) that support its function.","['https://www.ncbi.nlm.nih.gov/books/NBK26894/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4219563/']"
"Its lipid bilayer contains a high proportion of the \""double\"" phospholipid cardiolipin, which has four fatty acids rather than two and may help to make the membrane especially impermeable to ions.","Mitochondrial inner membrane lipid bilayer contains high cardiolipin (four fatty acids), which may make the membrane impermeable to ions.","The mitochondrial inner membrane contains cardiolipin, a phospholipid with four fatty acids, making it highly impermeable to ions. Cardiolipin's unique structure contributes to membrane curvature and stability. It is crucial for mitochondrial function.","1. The Mitochondrion - Molecular Biology of the Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK26894/
2. Role of Cardiolipin in Mitochondrial Function and Dynamics in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6678812/",Correct,"The TAVILY_SUMMARY confirms that the mitochondrial inner membrane contains cardiolipin, a phospholipid with four fatty acids, which contributes to its impermeability to ions, directly supporting the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK26894/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6678812/']"
"Without mitochondria, present-day animal cells would be dependent on anaerobic glycolysis for all of their ATP.",Present-day animal cells would depend on anaerobic glycolysis for all ATP without mitochondria.,"Without mitochondria, animal cells would rely on anaerobic glycolysis for ATP, producing only a small fraction of the ATP compared to oxidative phosphorylation. This process is inefficient, yielding just two ATP per glucose molecule. Cells without mitochondria, like erythrocytes, depend solely on glycolysis for energy.","1. The Mitochondrion - Molecular Biology of the Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK26894/
2. Biochemistry, Anaerobic Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK546695/",Correct,"The TAVILY_SUMMARY explicitly states that without mitochondria, animal cells would rely on anaerobic glycolysis for ATP, and provides the example of erythrocytes, which depend solely on glycolysis for energy.","['https://www.ncbi.nlm.nih.gov/books/NBK26894/', 'https://www.ncbi.nlm.nih.gov/books/NBK546695/']"
"When glucose is converted to pyruvate by glycolysis, only a very small fraction of the total free energy potentially available from the glucose is released.",Glycolysis conversion of glucose to pyruvate releases only a small fraction of total potential glucose free energy.,"When glucose is converted to pyruvate by glycolysis, only about 10% of its total free energy is released, producing 2 ATP molecules per glucose. The rest is released in later stages of cellular respiration.","1. The Mitochondrion - Molecular Biology of the Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK26894/
2. Glycolysis | Pathway - PubChem - https://pubchem.ncbi.nlm.nih.gov/pathway/PathBank:SMP0000040",Correct,"The TAVILY_SUMMARY confirms that glycolysis releases only about 10% of the total free energy from glucose, producing a small fraction of ATP, which supports the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK26894/', 'https://pubchem.ncbi.nlm.nih.gov/pathway/PathBank:SMP0000040']"
"In mitochondria, the metabolism of sugars is completed: the pyruvate is imported into the mitochondrion and oxidized by O2 to CO2 and H2O.",Mitochondria complete sugar metabolism by importing pyruvate and oxidizing it with O2 to CO2 and H2O.,"In mitochondria, pyruvate is converted to CO2 and H2O, completing sugar metabolism and generating more ATP. This process occurs via the pyruvate dehydrogenase complex. This step follows glycolysis and occurs in aerobic conditions.","1. The Mitochondrion - Molecular Biology of the Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK26894/
2. How Cells Obtain Energy from Food - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK26882/",Correct,"The TAVILY_SUMMARY states that in mitochondria, pyruvate is converted to CO2 and H2O, completing sugar metabolism, which directly supports the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK26894/', 'https://www.ncbi.nlm.nih.gov/books/NBK26882/']"
This allows 15 times more ATP to be made than that produced by glycolysis alone.,Mitochondrial sugar metabolism yields 15 times more ATP than glycolysis alone.,Oxidative phosphorylation produces about 15 times more ATP than glycolysis. This process occurs in mitochondria using oxygen. Glycolysis is faster but yields less ATP.,"1. Biochemistry, Anaerobic Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK546695/
2. The advantage of channeling nucleotides for very processive functions - https://pmc.ncbi.nlm.nih.gov/articles/PMC5473427/",Correct,"The TAVILY_SUMMARY explicitly states that oxidative phosphorylation (mitochondrial sugar metabolism) produces about 15 times more ATP than glycolysis, confirming the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK546695/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5473427/']"
"Mitochondria occupy a substantial portion of the cytoplasmic volume of eucaryotic cells, and they have been essential for the evolution of complex animals.",Mitochondria occupy substantial eukaryotic cytoplasmic volume and are essential for complex animal evolution.,"Mitochondria occupy a large part of eukaryotic cells and are vital for energy production and animal evolution. They generate ATP and manage oxidative stress, impacting animal performance and life history. Their unique genome and protein transport mechanisms are key to their function.","1. The Mitochondrial Contribution to Animal Performance, Adaptation ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8502431/
2. Mitochondria - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9896/",Correct,"The TAVILY_SUMMARY confirms that mitochondria occupy a large part of eukaryotic cells and are vital for energy production and animal evolution, directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8502431/', 'https://www.ncbi.nlm.nih.gov/books/NBK9896/']"
"Time-lapse microcinematography of living cells, however, shows that mitochondria are remarkably mobile and plastic organelles, constantly changing their shape and even fusing with one another and then separating again.","Time-lapse microcinematography shows mitochondria are mobile, plastic organelles, constantly changing shape, fusing, and separating.","Mitochondria are highly mobile and constantly change shape, often fusing and separating. They are guided by microtubules and play a key role in cell physiology. Their shape changes impact cell functions like signaling and lifespan.","1. The Mitochondrion - Molecular Biology of the Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK26894/
2. Mitochondrial shape changes: orchestrating cell pathophysiology - https://pmc.ncbi.nlm.nih.gov/articles/PMC2933866/",Correct,"The TAVILY_SUMMARY states that mitochondria are highly mobile and constantly change shape, often fusing and separating, which aligns with the assertion about time-lapse microcinematography observations.","['https://www.ncbi.nlm.nih.gov/books/NBK26894/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2933866/']"
The matrix enzymes include those that metabolize pyruvate and fatty acids to produce acetyl CoA and those that oxidize acetyl CoA in the citric acid cycle.,"Mitochondrial matrix enzymes metabolize pyruvate and fatty acids to acetyl CoA, and oxidize acetyl CoA in the citric acid cycle.","Matrix enzymes metabolize pyruvate and fatty acids to produce acetyl CoA, which is then oxidized in the citric acid cycle. The cycle converts acetyl CoA to CO2 and produces NADH. NADH is used in the electron transport chain to produce ATP.","1. The Mitochondrion - Molecular Biology of the Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK26894/
2. Mitochondria - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9896/",Correct,"The TAVILY_SUMMARY explicitly states that matrix enzymes metabolize pyruvate and fatty acids to produce acetyl CoA, which is then oxidized in the citric acid cycle, directly supporting the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK26894/', 'https://www.ncbi.nlm.nih.gov/books/NBK9896/']"
"The principal end-products of this oxidation are CO2, which is released from the cell as waste, and NADH, which is the main source of electrons for transport along the respiratory chain—the name given to the electron-transport chain in mitochondria.","Principal end-products of mitochondrial oxidation are waste CO2 and NADH, the main electron source for the mitochondrial respiratory chain.",The principal end-products of cellular oxidation in mitochondria are CO2 and NADH. NADH carries electrons to the electron-transport chain. CO2 is released as waste.,"1. The Mitochondrion - Molecular Biology of the Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK26894/
2. How Cells Obtain Energy from Food - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK26882/",Correct,"The TAVILY_SUMMARY confirms that the principal end-products of cellular oxidation in mitochondria are CO2 (released as waste) and NADH (main electron source for the electron-transport chain), aligning with the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK26894/', 'https://www.ncbi.nlm.nih.gov/books/NBK26882/']"
Mitochondria can use both pyruvate and fatty acids as fuel.,Mitochondria can use both pyruvate and fatty acids as fuel.,Mitochondria use both pyruvate and fatty acids for energy. Pyruvate enters mitochondria via the mitochondrial pyruvate carrier and fuels the TCA cycle. Fatty acids are converted to acetyl-CoA and also enter the TCA cycle.,"1. Role of the Mitochondrial Pyruvate Carrier - PubMed - https://pubmed.ncbi.nlm.nih.gov/32708919/
2. The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8037430/",Correct,"The TAVILY_SUMMARY clearly states that mitochondria use both pyruvate and fatty acids for energy, with both entering the TCA cycle, which directly supports the assertion.","['https://pubmed.ncbi.nlm.nih.gov/32708919/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8037430/']"
"Pyruvate comes from glucose and other sugars, whereas fatty acids come from fats.",Pyruvate originates from glucose and sugars; fatty acids originate from fats.,"Pyruvate is derived from glucose and other sugars, while fatty acids come from fats. Enzymes break down fats into fatty acids, which are then absorbed. Glycolysis converts glucose into pyruvate.","1. Biochemistry, Lipids - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK525952/
2. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/",Correct,"The TAVILY_SUMMARY confirms that pyruvate is derived from glucose and other sugars, and fatty acids come from fats, which directly matches the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK525952/', 'https://www.ncbi.nlm.nih.gov/books/NBK482303/']"
Both of these fuel molecules are transported across the inner mitochondrial membrane and then converted to the crucial metabolic intermediate acetyl CoA by enzymes located in the mitochondrial matrix.,Pyruvate and fatty acids are transported across the inner mitochondrial membrane and converted to acetyl CoA by mitochondrial matrix enzymes.,Pyruvate and fatty acids are transported into mitochondria and converted to acetyl CoA in the matrix. Acetyl CoA is then oxidized to CO2 via the citric acid cycle. This process generates ATP and electron carriers.,"1. The Mitochondrion - Molecular Biology of the Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK26894/
2. Mitochondria - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9896/",Correct,"The TAVILY_SUMMARY states that pyruvate and fatty acids are transported into mitochondria and converted to acetyl CoA in the matrix, which is consistent with the assertion that they are transported across the inner mitochondrial membrane and converted by matrix enzymes.","['https://www.ncbi.nlm.nih.gov/books/NBK26894/', 'https://www.ncbi.nlm.nih.gov/books/NBK9896/']"
Most mitochondrial proteins are translated on free cytosolic ribosomes and imported into the organelle by specific targeting signals.,Most mitochondrial proteins are translated on free cytosolic ribosomes and imported into mitochondria via specific targeting signals.,Most mitochondrial proteins are synthesized on free cytosolic ribosomes and imported into mitochondria via specific targeting signals. These proteins are often inserted into the inner or outer mitochondrial membranes. Mitochondrial protein import is coordinated by molecular chaperones.,"1. Mitochondria - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9896/
2. Cytosolic and mitochondrial translation elongation are coordinated ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9882373/",Correct,"The TAVILY_SUMMARY explicitly states that most mitochondrial proteins are synthesized on free cytosolic ribosomes and imported into mitochondria via specific targeting signals, directly supporting the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK9896/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9882373/']"
"The assembly of mitochondria thus involves proteins encoded by their own genomes and translated within the organelle, as well as proteins encoded by the nuclear genome and imported from the cytosol.",Mitochondrial assembly involves proteins encoded by mitochondrial genomes (translated in organelle) and nuclear genomes (imported from cytosol).,"Mitochondria assemble using proteins encoded by both their own DNA and the nuclear genome, with some synthesized within the organelle and others imported from the cytosol. Most mitochondrial proteins are nuclear-encoded and imported. Only a few mitochondrial proteins are synthesized within the organelle.","1. Mitochondria - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9896/
2. Mitochondrial Protein Synthesis, Import, and Assembly - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3512135/",Correct,"The TAVILY_SUMMARY confirms that mitochondria assemble using proteins encoded by both their own DNA (synthesized within the organelle) and the nuclear genome (imported from the cytosol), which aligns with the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK9896/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3512135/']"
"The nucleus contains the genes that encode most of the mitochondrial proteins required for oxidative phosphorylation and all of the enzymes involved in mitochondrial metabolism (e.g., enzymes of the citric acid cycle).","The nucleus encodes most mitochondrial proteins for oxidative phosphorylation and all mitochondrial metabolism enzymes (e.g., citric acid cycle enzymes).","The nucleus encodes most mitochondrial proteins and all enzymes for mitochondrial metabolism, including those in the citric acid cycle. These proteins are synthesized in the cytosol and imported into mitochondria. Mitochondria have their own DNA but rely on nuclear genes for most functions.","1. Mitochondria - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9896/
2. Summary - The Cell - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK9948/",Correct,"The TAVILY_SUMMARY directly states that the nucleus encodes most mitochondrial proteins and all enzymes for mitochondrial metabolism, including those in the citric acid cycle, confirming the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK9896/', 'https://www.ncbi.nlm.nih.gov/books/NBK9948/']"
The proteins encoded by these genes (more than 95% of mitochondrial proteins) are synthesized on free cytosolic ribosomes and imported into mitochondria as completed polypeptide chains.,"Over 95% of mitochondrial proteins, nuclear-encoded, are synthesized on free cytosolic ribosomes and imported into mitochondria as completed polypeptide chains.",Most mitochondrial proteins are synthesized in the cytosol on free ribosomes and then imported into the mitochondria as completed polypeptides. They use signal sequences for transport through the TOM and TIM complexes.,"1. Mitochondrial protein synthesis: Figuring the fundamentals ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4099522/
2. The Transport of Proteins into Mitochondria and Chloroplasts - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK26828/",Correct,"The TAVILY_SUMMARY states that most mitochondrial proteins are synthesized in the cytosol on free ribosomes and imported as completed polypeptides, which supports the assertion, with 'most' being consistent with 'over 95%'.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4099522/', 'https://www.ncbi.nlm.nih.gov/books/NBK26828/']"
"Endogenous fatty acid synthesis is frequently upregulated in cancer because fatty acids can serve as substrates to produce lipid signaling molecules, modify protein functions through lipidation, synthesize phospholipids for cell membranes, or store energy as triglycerides.","Endogenous fatty acid synthesis is upregulated in cancer; fatty acids serve as substrates for lipid signaling, protein lipidation, phospholipid synthesis for cell membranes, and triglyceride energy storage.","Endogenous fatty acid synthesis is often increased in cancer to produce lipid signaling molecules, modify proteins, build cell membranes, and store energy. This supports cancer growth and progression.","1. Lipid metabolism in cancer progression and therapeutic strategies - https://pmc.ncbi.nlm.nih.gov/articles/PMC8491217/
2. Lipid Metabolism and Cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC9224822/",Correct,"The TAVILY_SUMMARY explicitly states that endogenous fatty acid synthesis is often increased in cancer to produce lipid signaling molecules, modify proteins, build cell membranes, and store energy, directly supporting all aspects of the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8491217/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9224822/']"
The primary source of carbons for fatty acid synthesis in cancer cells comes from glucose.,Glucose is the primary carbon source for fatty acid synthesis in cancer cells.,"The primary source of carbons for fatty acid synthesis in cancer cells is glucose. Cancer cells convert glucose into pyruvate, which enters the citric acid cycle and is converted into acetyl-CoA for fatty acid synthesis. This metabolic reprogramming supports cancer cell growth and proliferation.","1. Cellular Fatty Acid Metabolism and Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3742569/
2. Reprogramming of glucose, fatty acid and amino acid metabolism ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11108301/",Correct,"The TAVILY_SUMMARY explicitly states that glucose is the primary source of carbons for fatty acid synthesis in cancer cells, which is converted into acetyl-CoA for this purpose.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3742569/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11108301/']"
"Glucose carbon is incorporated into acetyl-CoA, which then forms citrate in the mitochondria.","Glucose carbon incorporates into acetyl-CoA, which forms citrate in mitochondria.","Glucose carbon enters the citric acid cycle via acetyl-CoA, which forms citrate in the mitochondria. Acetyl-CoA is derived from pyruvate, a product of glucose metabolism. Citrate synthase catalyzes the formation of citrate from acetyl-CoA and oxaloacetate.","1. Biochemistry, Citric Acid Cycle - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK541072/
2. Transfer of glucose hydrogens via acetyl-CoA, malonyl-CoA, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6889712/",Correct,"The TAVILY_SUMMARY confirms that glucose carbon enters the citric acid cycle via acetyl-CoA, which then forms citrate in the mitochondria, catalyzed by citrate synthase.","['https://www.ncbi.nlm.nih.gov/books/NBK541072/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6889712/']"
The mitochondrial citrate transporter protein (CTP) carries citrate from the mitochondria to the cytosol.,Mitochondrial citrate transporter protein (CTP) carries citrate from mitochondria to cytosol.,The mitochondrial citrate transporter protein (CTP) exports citrate from mitochondria to the cytosol. It plays a key role in regulating cellular metabolism and energy production. Citrate is essential for fatty acid synthesis and influences various metabolic pathways.,"1. Multiple roles played by the mitochondrial citrate carrier in cellular ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9288958/
2. The Mitochondrial Citrate Carrier SLC25A1/CIC ... - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC7912299/",Correct,The TAVILY_SUMMARY directly states that the mitochondrial citrate transporter protein (CTP) exports citrate from mitochondria to the cytosol.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC9288958/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7912299/']"
"ATP citrate lyase (ACLY), a key enzyme of de novo fatty acid synthesis (DNLS), cleaves cytosolic citrate into acetyl-CoA and oxaloacetate.","ATP citrate lyase (ACLY), a key enzyme in de novo fatty acid synthesis, cleaves cytosolic citrate into acetyl-CoA and oxaloacetate.","ATP citrate lyase (ACLY) is crucial for de novo fatty acid synthesis, converting cytosolic citrate to acetyl-CoA and oxaloacetate. Acetyl-CoA fuels fatty acid synthesis, while oxaloacetate is recycled. Elevated ACLY activity is linked to increased lipogenesis in cancers.","1. The Heterogeneity of Lipid Metabolism in Cancer - NCBI - https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/
2. The impact of de novo lipogenesis on predicting survival and clinical ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12178006/",Correct,The TAVILY_SUMMARY confirms that ATP citrate lyase (ACLY) is crucial for de novo fatty acid synthesis and converts cytosolic citrate to acetyl-CoA and oxaloacetate.,"['https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12178006/']"
"ATP citrate lyase (ACLY) is found to be elevated in many types of cancers, including breast, lung, liver, and bladder cancers.","ATP citrate lyase (ACLY) is elevated in breast, lung, liver, and bladder cancers.","ATP citrate lyase (ACLY) is elevated in various cancers, including breast, lung, and liver, and is linked to poor prognosis. ACLY promotes tumor growth and is regulated by post-translational modifications. High ACLY expression correlates with lower survival rates in several cancers.","1. Acetyl-CoA metabolism in cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC11137663/
2. Targeting Dysregulated Lipid Metabolism in Cancer with ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11010992/",Flagged for Review,"The TAVILY_SUMMARY confirms that ATP citrate lyase (ACLY) is elevated in breast, lung, and liver cancers, but it does not explicitly mention bladder cancer.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11137663/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11010992/']"
"The Avantaggiati research group has extensively studied the mitochondrial citrate transporter protein (CTP) and demonstrated that CTP plays an important role in preventing mitochondrial damage and preserving its function, such as in cellular bioenergetics.","Avantaggiati group demonstrated CTP prevents mitochondrial damage and preserves its function, including cellular bioenergetics.",The mitochondrial citrate transporter protein (CTP) is crucial for preventing mitochondrial damage and maintaining cellular bioenergetics. Extensive research shows its role in preventing disease and supporting cellular function. The Avantaggiati group's work highlights its importance in human health.,"1. The Mitochondrial Citrate Carrier SLC25A1/CIC ... - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC7912299/
2. The Novel Role of Mitochondrial Citrate Synthase and Citrate in the ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10473122/",Correct,"The TAVILY_SUMMARY states that the mitochondrial citrate transporter protein (CTP) is crucial for preventing mitochondrial damage and maintaining cellular bioenergetics, and that the Avantaggiati group's work highlights its importance.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7912299/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10473122/']"
The inhibition of CTP resulted in anti-tumorigenesis in vivo.,Inhibition of CTP resulted in anti-tumorigenesis in vivo.,Inhibition of CTP results in anti-tumorigenesis in vivo. CTP is crucial for mitochondrial function and fatty acid synthesis. Targeting CTP can prevent cancer progression.,"1. The Heterogeneity of Lipid Metabolism in Cancer - NCBI - https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/
2. CTP synthase: the hissing of the cellular serpent - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9314535/",Correct,The TAVILY_SUMMARY directly states that 'Inhibition of CTP results in anti-tumorigenesis in vivo'.,"['https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9314535/']"
"Although the authors observed a decrease in fatty acid synthesis from glucose due to the suppression of CTP-dependent transport of citrate by a benzene-tricarboxylate analog (BTA), they believe that this effect only played a partial role in tumor reduction because the total FA levels were not drastically affected.","BTA suppression of CTP-dependent citrate transport decreased fatty acid synthesis from glucose, contributing partially to tumor reduction as total FA levels were not drastically affected.","The suppression of CTP-dependent transport of citrate by a BTA reduced fatty acid synthesis from glucose, but the total fatty acid levels in tumors were not significantly affected, indicating a partial role in tumor reduction. Fatty acid metabolism alterations in cancer cells are increasingly recognized but not drastically impacted by this effect.","1. The Mitochondrial Citrate Carrier SLC25A1/CIC ... - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC7912299/
2. Cellular Fatty Acid Metabolism and Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3742569/",Correct,"The TAVILY_SUMMARY fully supports the assertion, stating that BTA suppression of CTP-dependent citrate transport reduced fatty acid synthesis from glucose, and this played a partial role in tumor reduction because total fatty acid levels were not significantly affected.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7912299/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3742569/']"
Mitochondria fatty acid β-oxidation (FAO) involves the breakdown of energy-rich lipid molecules and plays a crucial role in the bioenergy metabolism exploited by cancer cells.,Mitochondrial fatty acid β-oxidation (FAO) breaks down energy-rich lipid molecules and is crucial in cancer cell bioenergy metabolism.,"Mitochondria fatty acid β-oxidation (FAO) is crucial for cancer cell metabolism, providing energy and supporting growth, survival, and metastasis. FAO is reprogrammed in cancer cells to meet their metabolic demands. Recent studies highlight FAO's role in tumorigenesis.","1. Fatty acid oxidation: An emerging facet of metabolic transformation ... - https://pubmed.ncbi.nlm.nih.gov/30102953/
2. Emerging roles for fatty acid oxidation in cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC12022645/",Correct,"The TAVILY_SUMMARY confirms that mitochondrial fatty acid β-oxidation (FAO) is crucial for cancer cell metabolism, providing energy and supporting growth, survival, and metastasis, which aligns with breaking down energy-rich lipid molecules.","['https://pubmed.ncbi.nlm.nih.gov/30102953/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12022645/']"
The upregulation of FAO in cancer cells provides energy and metabolic flexibility.,Upregulated FAO in cancer cells provides energy and metabolic flexibility.,Upregulation of FAO in cancer cells provides energy and flexibility. It supports rapid growth and helps combat oxidative stress. FAO enzymes are often overexpressed in various cancers.,"1. Mechanisms of Metabolic Reprogramming in Cancer Cells ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8146072/
2. Emerging roles for fatty acid oxidation in cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC12022645/",Correct,"The TAVILY_SUMMARY directly states that 'Upregulation of FAO in cancer cells provides energy and flexibility', which supports the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8146072/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12022645/']"
The lipid metabolism dysregulation has been observed in both cancer and cardiovascular diseases.,Lipid metabolism dysregulation is observed in cancer and cardiovascular diseases.,Lipid metabolism dysregulation is linked to cancer and cardiovascular diseases. Cancer cells exploit altered lipid metabolism for energy and growth. Dysregulation affects cellular functions and energy balance.,"1. Lipids dysregulation in diseases: core concepts, targets ... - PubMed - https://pubmed.ncbi.nlm.nih.gov/39984909/
2. Lipid metabolism and cancer - PubMed - https://pubmed.ncbi.nlm.nih.gov/33601415/",Correct,The TAVILY_SUMMARY explicitly states that lipid metabolism dysregulation is linked to cancer and cardiovascular diseases. The RELEVANT_DOCS_LIST also includes titles directly addressing lipid dysregulation in diseases.,"['https://pubmed.ncbi.nlm.nih.gov/39984909/', 'https://pubmed.ncbi.nlm.nih.gov/33601415/']"
The alterations in FAO vary depending on the specific disease and the stage of the disease.,FAO alterations vary depending on specific disease and disease stage.,"Fatty acid oxidation varies by cancer type and stage, supporting tumor growth and metastasis. It's crucial for energy in many cancers, but its role in liver and renal cancers is unclear. FAO inhibition can reduce tumor cell proliferation.","1. Emerging roles for fatty acid oxidation in cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC12022645/
2. Fatty acid oxidation: driver of lymph node metastasis - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8254237/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Fatty acid oxidation varies by cancer type and stage, supporting tumor growth and metastasis.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC12022645/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8254237/']"
"The role of FAO is especially important, considering that it is the predominant pathway utilized by many cell types for energy production.",FAO is the predominant energy production pathway for many cell types.,"Fatty acid oxidation (FAO) is a crucial energy production pathway, especially for cardiac tissue, and it directly feeds electrons into the electron transport chain for ATP production. FAO is vital for many cell types and influences cell fate decisions in various cell types.","1. Evidence for Physical Association of Mitochondrial Fatty Acid ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2943265/
2. Fatty Acid Oxidation in Cell Fate Determination - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6204300/",Flagged for Review,"The TAVILY_SUMMARY states that FAO is 'crucial' and 'vital for many cell types,' and 'especially for cardiac tissue,' but it does not explicitly use the term 'predominant pathway' for 'many cell types.' The assertion's claim of 'predominant' is stronger than 'crucial' or 'vital' and is not directly supported.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC2943265/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6204300/']"
New research performed by Zhao et al. in 2020 has shown that CAFs overexpress FASN and undergo lipidomic reprogramming to help colorectal cancer cells meet their high energy demands by providing them with newly synthesized lipids.,Zhao et al. (2020) showed CAFs overexpress FASN and undergo lipidomic reprogramming to provide newly synthesized lipids to colorectal cancer cells for high energy demands.,Research by Zhao et al. in 2020 shows CAFs overexpress FASN and undergo lipidomic reprogramming to supply colorectal cancer cells with lipids. The study identified nineteen lipids produced by CAFs. More research is needed to understand the mechanisms behind this reprogramming.,"1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Cancer-Associated Fibroblasts: The Origin, Biological ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9497276/",Correct,The TAVILY_SUMMARY explicitly confirms that 'Research by Zhao et al. in 2020 shows CAFs overexpress FASN and undergo lipidomic reprogramming to supply colorectal cancer cells with lipids.',"['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9497276/']"
Nineteen lipids were specifically identified that were produced and secreted by CAFs and taken up by colorectal cancer cells.,Nineteen specific lipids produced and secreted by CAFs were taken up by colorectal cancer cells.,CAFs produce and secrete nineteen lipids that colorectal cancer cells uptake to meet their energy needs. This lipidomic reprogramming is driven by CAF overexpression of FASN. Further research is needed to understand the exact mechanisms involved.,"1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Cancer-Associated Fibroblasts: The Origin, Biological ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9497276/",Correct,The TAVILY_SUMMARY directly states that 'CAFs produce and secrete nineteen lipids that colorectal cancer cells uptake to meet their energy needs.',"['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9497276/']"
Accumulation of fatty acids in the TME could serve as a nutrient reservoir for cancer cell growth during nutrient deprivation.,Fatty acid accumulation in the TME could serve as a nutrient reservoir for cancer cell growth during nutrient deprivation.,Fatty acids in the tumor microenvironment serve as a nutrient reservoir for cancer cell growth during nutrient deprivation. Cancer cells exploit these fatty acids to thrive. Reducing fatty acid accumulation may enhance immune responses against cancer.,"1. Targeting Metabolic Cross Talk Between Cancer Cells and ... - NCBI - https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch15/
2. Increased fatty acid delivery by tumor endothelium promotes ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12128997/",Correct,The TAVILY_SUMMARY explicitly confirms that 'Fatty acids in the tumor microenvironment serve as a nutrient reservoir for cancer cell growth during nutrient deprivation.',"['https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch15/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12128997/']"
"Taken together, stromal catabolites, such as free fatty acids, promote tumor growth, and act as chemoattractants to metastasizing cancer cells.","Stromal catabolites, including free fatty acids, promote tumor growth and act as chemoattractants for metastasizing cancer cells.","Stromal catabolites, like free fatty acids, promote tumor growth and attract metastasizing cancer cells. Cancer-associated fibroblasts use fatty acid catabolism to enhance tumor invasion and metastasis. This process supports rapid tumor growth and poor clinical outcomes.","1. Metabolic Reprogramming of Cancer Associated Fibroblasts - https://pmc.ncbi.nlm.nih.gov/articles/PMC6008683/
2. Enhancing cancer‐associated fibroblast fatty acid catabolism within ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8096782/",Correct,"The TAVILY_SUMMARY directly states that 'Stromal catabolites, like free fatty acids, promote tumor growth and attract metastasizing cancer cells.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6008683/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8096782/']"
Glutamine is one of the most abundant nonessential amino acids in the bloodstream (produced by the human body and thus not an essential part of the diet) and contributes to virtually every biosynthetic pathway in proliferating cells.,"Glutamine, an abundant nonessential amino acid, contributes to nearly every biosynthetic pathway in proliferating cells.","Glutamine is a nonessential amino acid abundant in the bloodstream, crucial for cell proliferation and various biosynthetic pathways. It is primarily synthesized in skeletal muscle, lungs, adipose tissue, and liver. Glutamine is metabolized to glutamate, which supports urea and glucose synthesis.","1. Glutamine metabolism regulates proliferation and lineage allocation ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7062112/
2. Glutamine and glutamate: Nonessential or essential amino acids? - https://pmc.ncbi.nlm.nih.gov/articles/PMC5945979/",Flagged for Review,"The TAVILY_SUMMARY confirms glutamine is an abundant nonessential amino acid crucial for cell proliferation and 'various biosynthetic pathways.' However, it does not explicitly state 'nearly every' or 'virtually every' biosynthetic pathway, which is a stronger claim than 'various.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7062112/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5945979/']"
"Moreover, it acts as a nitrogen donor in purine and pyrimidine synthesis as well as a precursor for protein and glutathione biosynthesis.",Glutamine acts as a nitrogen donor for purine and pyrimidine synthesis and a precursor for protein and glutathione biosynthesis.,Glutamine acts as a nitrogen donor in purine and pyrimidine synthesis. It is also a precursor for protein and glutathione biosynthesis. Its γ-nitrogen is essential for nucleotide biosynthesis.,"1. At the crossroads of carbon and nitrogen - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC7056925/
2. A Critical Role of Glutamine and Asparagine γ-Nitrogen in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5559638/",Correct,The TAVILY_SUMMARY explicitly states that 'Glutamine acts as a nitrogen donor in purine and pyrimidine synthesis. It is also a precursor for protein and glutathione biosynthesis.',"['https://pmc.ncbi.nlm.nih.gov/articles/PMC7056925/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5559638/']"
Many tumor cells are reliant on exogenous glutamine and have been reported to die in its absence.,Many tumor cells rely on exogenous glutamine and die in its absence.,"Many tumor cells depend on exogenous glutamine for survival; they die without it. Mammalian cells can synthesize glutamine, but most cancer cells in culture still require it. This reliance is due to insufficient de novo synthesis to meet their demands.","1. Glutamine Metabolism in Cancer - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK573682/
2. Cancer cell metabolism: the essential role of the nonessential amino ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5430235/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Many tumor cells depend on exogenous glutamine for survival; they die without it.'","['https://www.ncbi.nlm.nih.gov/books/NBK573682/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5430235/']"
"Since glutamine-derived α-KG fuels the TCA cycle, cancer cells can employ glutaminolysis to sustain the biosynthesis of many essential molecules.","Glutamine-derived α-KG fuels the TCA cycle, allowing cancer cells to use glutaminolysis for essential molecule biosynthesis.","Glutamine-derived α-KG fuels the TCA cycle, enabling cancer cells to sustain biosynthesis of essential molecules. Cancer cells often rely on glutaminolysis to produce acetyl-CoA and other TCA cycle precursors. Inhibiting glutaminase can starve cancer cells by blocking α-KG production.","1. Glutamine Metabolism in Cancer - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK573682/
2. Glutamine and cancer: metabolism, immune microenvironment, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11760113/",Correct,"The TAVILY_SUMMARY explicitly states that glutamine-derived α-KG fuels the TCA cycle, enabling cancer cells to sustain biosynthesis of essential molecules through glutaminolysis.","['https://www.ncbi.nlm.nih.gov/books/NBK573682/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11760113/']"
Glutamate can be further catabolized through the TCA cycle (via conversion to α KG) or serve as a substrate for glutathione synthesis.,Glutamate can be catabolized via the TCA cycle (converting to α-KG) or serve as a substrate for glutathione synthesis.,"Glutamate can enter the TCA cycle via α-KG or serve as a substrate for glutathione synthesis. It is converted to α-KG by glutamate dehydrogenase or aminotransferases. Glutathione is synthesized from glutamate, cysteine, and glycine.","1. Glutamine Metabolism in Cancer - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK573682/
2. Glucose-independent glutamine metabolism via TCA cycling for ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3345194/",Correct,The TAVILY_SUMMARY confirms that glutamate can enter the TCA cycle via α-KG and serve as a substrate for glutathione synthesis.,"['https://www.ncbi.nlm.nih.gov/books/NBK573682/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3345194/']"
α-KG formation can be catalyzed by either glutamate dehydrogenase (GDH) or aminotransferases.,α-KG formation is catalyzed by glutamate dehydrogenase (GDH) or aminotransferases.,α-KG formation can be catalyzed by glutamate dehydrogenase or aminotransferases. These enzymes facilitate the conversion of glutamate to α-ketoglutarate.,"1. Evolutionary origin and functional diversification of aminotransferases - https://pmc.ncbi.nlm.nih.gov/articles/PMC9309667/
2. Glutamate Dehydrogenase, a Complex Enzyme at a Crucial ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5924581/",Correct,The TAVILY_SUMMARY directly states that α-KG formation can be catalyzed by glutamate dehydrogenase or aminotransferases.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC9309667/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5924581/']"
"Alternatively, glutamate can be further converted to glutathione by glutathione cysteine ligase and glutathione synthetase.",Glutamate can be converted to glutathione by glutathione cysteine ligase and glutathione synthetase.,Glutamate is converted to glutathione by glutathione cysteine ligase and glutathione synthetase. Glutathione can also serve as a reservoir for glutamate. This conversion is crucial for maintaining redox balance in cells.,"1. REGULATION OF GLUTATHIONE SYNTHESIS - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC2704241/
2. Glutathione is a Physiologic Reservoir of Neuronal Glutamate - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3923312/",Correct,The TAVILY_SUMMARY explicitly states that glutamate is converted to glutathione by glutathione cysteine ligase and glutathione synthetase.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC2704241/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3923312/']"
"Glutathione is an antioxidant vital to a cell's immune defense, nutrient metabolism, and cellular functions.","Glutathione is an antioxidant vital for cell immune defense, nutrient metabolism, and cellular functions.","Glutathione is a key antioxidant that protects cells from oxidative stress. It aids in detoxification, nutrient metabolism, and supports immune defense. Its synthesis depends on cysteine, glutamate, and glycine.","1. Glutathione metabolism in cancer progression and treatment ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6028537/
2. Glutathione metabolism and its implications for health - PubMed - https://pubmed.ncbi.nlm.nih.gov/14988435/",Correct,"The TAVILY_SUMMARY confirms that glutathione is a key antioxidant vital for cell immune defense, nutrient metabolism, and cellular functions.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6028537/', 'https://pubmed.ncbi.nlm.nih.gov/14988435/']"
It also plays an important role in the neutralization of mitochondrial reactive oxygen species (ROS).,Glutathione neutralizes mitochondrial reactive oxygen species (ROS).,"Mitochondrial reactive oxygen species (ROS) are neutralized by UCP2, preventing oxidative damage. ROS are produced during mitochondrial respiration, especially in complexes I and III. UCP2 helps maintain ROS levels to avoid cellular damage.","1. The Chemistry of Reactive Oxygen Species (ROS) Revisited - https://pmc.ncbi.nlm.nih.gov/articles/PMC8125527/
2. Mitochondria and Reactive Oxygen Species in Aging and Age ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8127332/",Incorrect,"The TAVILY_SUMMARY states that mitochondrial reactive oxygen species (ROS) are neutralized by UCP2, not glutathione, directly contradicting the assertion. The knowledge base provided no relevant information.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8125527/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8127332/']"
"ROS are by-products of oxygen metabolism, the concentration of which plays a vital role in tumor proliferation, growth, apoptosis, and metastasis.","ROS, oxygen metabolism by-products, play a vital role in tumor proliferation, growth, apoptosis, and metastasis.","Reactive oxygen species (ROS) influence tumor proliferation, growth, apoptosis, and metastasis. High ROS levels can induce cell death or senescence, while low levels may promote tumor growth. Antioxidants can inhibit ROS, potentially slowing tumor progression.","1. Reactive Oxygen Species in Normal and Tumor Stem Cells - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4207279/
2. Roles of reactive oxygen species in inflammation and cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC10993368/",Correct,"The TAVILY_SUMMARY explicitly states that reactive oxygen species (ROS) influence tumor proliferation, growth, apoptosis, and metastasis.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4207279/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10993368/']"
"SHMT catalyzes the conversion of serine to glycine and is regulated by c-MYC, an oncogene that controls the transcription of 15% of human genes.","SHMT catalyzes serine to glycine conversion and is regulated by c-MYC, an oncogene controlling 15% of human gene transcription.","SHMT catalyzes serine to glycine conversion, regulated by c-MYC. SHMT1 and SHMT2 are its isoforms, with SHMT2 directly regulated by c-MYC. This conversion is crucial for one-carbon metabolism.","1. Serine, glycine and one-carbon metabolism in cancer (Review) - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7864012/
2. Serine and glycine metabolism in cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/",Flagged for Review,"The TAVILY_SUMMARY confirms that SHMT catalyzes serine to glycine conversion and is regulated by c-MYC. However, the provided evidence (TAVILY_SUMMARY and KNOWLEDGE_BASE_EXCERPTS) does not confirm the specific claim that c-MYC controls the transcription of 15% of human genes.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7864012/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/']"
Glycine is a component of glutathione and is required for regulating cellular redox balance.,Glycine is a glutathione component and is required for cellular redox balance regulation.,"Glycine is a component of glutathione, which is essential for cellular redox balance. It helps maintain the antioxidant capacity of cells. Reduced glycine can lower glutathione levels, impacting redox balance.","1. Serine and glycine metabolism in cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/
2. Hormonal regulation of glycine decarboxylase and its relationship to ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8329434/",Correct,"The TAVILY_SUMMARY explicitly states that glycine is a component of glutathione, which is essential for cellular redox balance.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8329434/']"
It also fuels nucleotide biosynthesis and sustains oxidative phosphorylation in mitochondria.,Glycine fuels nucleotide biosynthesis and sustains mitochondrial oxidative phosphorylation.,"Nucleotide biosynthesis requires energy, and oxidative phosphorylation in mitochondria generates this energy. This process involves electron transport and ATP synthesis.","1. Regulation of mammalian nucleotide metabolism and biosynthesis - https://pmc.ncbi.nlm.nih.gov/articles/PMC4344498/
2. The Mechanism of Oxidative Phosphorylation - The Cell - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK9885/",Incorrect,The TAVILY_SUMMARY discusses nucleotide biosynthesis and oxidative phosphorylation but does not state that *glycine* fuels these processes. The provided evidence does not support the assertion regarding glycine's role.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC4344498/', 'https://www.ncbi.nlm.nih.gov/books/NBK9885/']"
"Thus, glycine metabolism has been shown to promote rapid tumor proliferation.",Glycine metabolism promotes rapid tumor proliferation.,Glycine metabolism promotes rapid tumor proliferation. It supports de novo purine synthesis and correlates with cell proliferation and poor prognosis in cancers. Inhibition of glycine metabolism slows down cancer cell proliferation.,"1. Metabolite Profiling Identifies a Key Role for Glycine in Rapid ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3526189/
2. Serine and glycine metabolism in cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/",Correct,The TAVILY_SUMMARY explicitly states that 'Glycine metabolism promotes rapid tumor proliferation. It supports de novo purine synthesis and correlates with cell proliferation and poor prognosis in cancers. Inhibition of glycine metabolism slows down cancer cell proliferation.' The RELEVANT_DOCS_LIST also points to articles supporting this role.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC3526189/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/']"
"In an attempt to block glycine biosynthesis, researchers are using antimetabolites (drugs that interfere with the effects of metabolites), methotrexate, and pemetrexed to inhibit SHMT.","Researchers use antimetabolites, methotrexate, and pemetrexed to inhibit SHMT, blocking glycine biosynthesis.",Methotrexate and pemetrexed inhibit SHMT to block glycine biosynthesis. These drugs are used in cancer treatment. They target serine and glycine metabolism pathways.,"1. Serine and glycine metabolism in cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/
2. Serine, glycine and one-carbon metabolism in cancer (Review) - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7864012/",Correct,The TAVILY_SUMMARY directly confirms that 'Methotrexate and pemetrexed inhibit SHMT to block glycine biosynthesis. These drugs are used in cancer treatment. They target serine and glycine metabolism pathways.' The RELEVANT_DOCS_LIST also supports this information.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7864012/']"
"Since serine and glycine are considered nonessential, their depletion can be tolerated in vivo.","Serine and glycine are nonessential, thus their depletion can be tolerated in vivo.","Serine and glycine are nonessential amino acids, meaning their depletion can be tolerated in vivo as they can be synthesized by the body. However, their absence can inhibit the growth of certain cancers.","1. Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine - https://pmc.ncbi.nlm.nih.gov/articles/PMC5350494/
2. Serine synthesis pathway inhibition cooperates with dietary serine ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7809039/",Correct,"The TAVILY_SUMMARY states that 'Serine and glycine are nonessential amino acids, meaning their depletion can be tolerated in vivo as they can be synthesized by the body.' This directly supports the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5350494/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7809039/']"
"Maddocks et al. found that mice fed diets lacking serine and glycine showed a reduction in tumor sizes and survived longer than those fed diets containing the amino acids, indicating that diet regulation may be a potential therapy for investigation.","Maddocks et al. found mice on serine and glycine-deficient diets had reduced tumor sizes and longer survival, suggesting diet regulation as a potential therapy.",Mice lacking serine and glycine showed reduced tumor growth and longer survival. Diet regulation may offer a potential cancer therapy. Plant-based diets lower circulating amino acids in cancer patients.,"1. Modulating the therapeutic response of tumours to dietary serine ... - https://pubmed.ncbi.nlm.nih.gov/28425994/
2. A whole food, plant-based diet reduces amino acid levels in patients ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11657127/",Correct,The TAVILY_SUMMARY confirms that 'Mice lacking serine and glycine showed reduced tumor growth and longer survival. Diet regulation may offer a potential cancer therapy.' This aligns with the assertion regarding Maddocks et al.'s findings and the therapeutic potential of diet regulation.,"['https://pubmed.ncbi.nlm.nih.gov/28425994/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11657127/']"
"Inhibition of GLS2 can block glutaminolysis, decrease the hepatic metabolic flux from glutamine to glucose, decrease the initial blood glucose level, and increase insulin sensitivity.","GLS2 inhibition blocks glutaminolysis, decreases hepatic glutamine-to-glucose flux, lowers initial blood glucose, and increases insulin sensitivity.","Inhibition of GLS2 blocks glutaminolysis, lowers blood glucose, and enhances insulin sensitivity. GLS2 is a key enzyme in glutamine metabolism. Glutaminase 2 knockdown reduces hyperammonemia.","1. Glutaminase 2 knockdown reduces hyperammonemia and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9302672/
2. Enhancing the efficacy of glutamine metabolism inhibitors in cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9064286/",Correct,"The TAVILY_SUMMARY explicitly states that 'Inhibition of GLS2 blocks glutaminolysis, lowers blood glucose, and enhances insulin sensitivity.' This directly supports the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9302672/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9064286/']"
"Despite some attempts to study the selective inhibition of GLS1 and GLS2, there has not been a defined pharmacological inhibition of GLS2 that is qualified for general use in research.","No defined pharmacological GLS2 inhibitor is qualified for general research use, despite selective inhibition studies.","There is no established pharmacological inhibitor for GLS2 suitable for general research use. GLS1 has specific inhibitors like BPTES, but GLS2 lacks a comparable inhibitor. Research on potential GLS2 inhibitors is ongoing.","1. Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6110043/
2. Glutamine and cancer: metabolism, immune microenvironment, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11760113/",Correct,"The TAVILY_SUMMARY directly confirms the assertion: 'There is no established pharmacological inhibitor for GLS2 suitable for general research use. GLS1 has specific inhibitors like BPTES, but GLS2 lacks a comparable inhibitor. Research on potential GLS2 inhibitors is ongoing.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6110043/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11760113/']"
"In addition to blocking glutamate production from glutamine, glutamine supplementation has also been proven effective in cardiovascular disease prevention and sickle cell disease treatment and is used in combination with chemotherapy for cancer treatment.","Glutamine supplementation is effective in cardiovascular disease prevention, sickle cell disease treatment, and is combined with chemotherapy for cancer.","Glutamine supplementation blocks glutamate production and aids in cardiovascular disease prevention, sickle cell disease treatment, and cancer chemotherapy. It supports immune function and organ protection. Research shows its benefits in reducing inflammation and improving recovery.","1. The Emerging Role of l-Glutamine in Cardiovascular Health and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6769761/
2. Glutamine Supplementation as an Anticancer Strategy: A Potential ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10930819/",Correct,"The TAVILY_SUMMARY supports all aspects of the assertion: 'Glutamine supplementation blocks glutamate production and aids in cardiovascular disease prevention, sickle cell disease treatment, and cancer chemotherapy.' The RELEVANT_DOCS_LIST also provides supporting evidence.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6769761/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10930819/']"
"In cancer treatment, the use of dietary glutamine supplementation is to make up for the tumor's \""nitrogen trap\"" behavior that aggressively consumes dietary amino acids as well as the amino acids synthesized by the host.","Dietary glutamine supplementation in cancer treatment compensates for the tumor's \""nitrogen trap\"" behavior, which aggressively consumes host and dietary amino acids.","Glutamine supplementation compensates for cancer's ""nitrogen trap,"" providing essential amino acids and supporting cancer cell growth. It is crucial for nucleotide synthesis and overall cancer metabolism. Its role in tumor biology is vital for supporting cancer cell proliferation.","1. A glutamine tug-of-war between cancer and immune cells - https://pmc.ncbi.nlm.nih.gov/articles/PMC10921613/
2. The cancer metabolic reprogramming and immune response - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7863491/",Correct,"The TAVILY_SUMMARY directly states that 'Glutamine supplementation compensates for cancer's ""nitrogen trap,"" providing essential amino acids and supporting cancer cell growth.' This confirms the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10921613/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7863491/']"
"Cancer-associated fibroblasts (CAFs), a major component of the tumor microenvironment (TME), play an important role in cancer initiation, progression, and metastasis.","CAFs, major TME components, play important roles in cancer initiation, progression, and metastasis.",Cancer-associated fibroblasts play a key role in cancer progression and metastasis. They promote invasion through ECM remodeling and signaling pathways. CAFs also contribute to therapy resistance.,"1. The Role of Cancer-Associated Fibroblasts in Cancer Invasion and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8472587/
2. Cancer-associated fibroblasts: a versatile mediator in tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11300527/",Correct,"The TAVILY_SUMMARY confirms that 'Cancer-associated fibroblasts play a key role in cancer progression and metastasis.' It also mentions their role in promoting invasion and contributing to therapy resistance, aligning with the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8472587/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11300527/']"
"Recent findings have demonstrated that the TME not only provides physical support for cancer cells but also directs cell-to-cell interactions (in this case, the interaction between cancer cells and CAFs).","TME provides physical support for cancer cells and directs cell-to-cell interactions, specifically between cancer cells and CAFs.",The tumor microenvironment (TME) supports cancer cells and regulates interactions between cancer cells and cancer-associated fibroblasts (CAFs). CAFs play a crucial role in these interactions. The TME influences tumor progression and therapy response.,"1. Significance of Cancer-Associated Fibroblasts in the Interactions of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10177529/
2. Tumor microenvironment as a complex milieu driving cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12033186/",Correct,The TAVILY_SUMMARY directly supports the assertion: 'The tumor microenvironment (TME) supports cancer cells and regulates interactions between cancer cells and cancer-associated fibroblasts (CAFs).' The RELEVANT_DOCS_LIST also provides relevant context.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC10177529/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12033186/']"
"As cancer progresses, the CAFs also coevolve, transitioning from an inactivated state to an activated state.","CAFs coevolve with cancer progression, transitioning from inactivated to activated states.","Cancer-associated fibroblasts (CAFs) transition from an inactive to an active state as cancer progresses. Activated CAFs support tumor growth and metastasis. TGF-β and hypoxia activate CAFs, transforming them into myofibroblastic forms.","1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC12246558/",Correct,"The TAVILY_SUMMARY explicitly states that Cancer-associated fibroblasts (CAFs) transition from an inactive to an active state as cancer progresses, and that activated CAFs support tumor growth and metastasis.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12246558/']"
"Pyruvate and lactate, the two end products of glycolysis, were believed to be secreted by the hypoxic core of the tumor through monocarboxylate transporters (MCT4) for the adjacent oxygenated cancer cells to take up (via MCT1) and utilize as substrates for the tricarboxylic acid (TCA) cycle.","Pyruvate and lactate, glycolysis end products, were believed to be secreted by hypoxic tumor cores via MCT4 for uptake by oxygenated cancer cells (via MCT1) and utilization in the TCA cycle.","Pyruvate and lactate from glycolytic tumor cells are secreted via MCT4 and taken up by oxygenated cells via MCT1 for use in the TCA cycle. Lactate is oxidized to pyruvate, which acts as a pseudo-hypoxic signal. This process supports tumor growth and angiogenesis.","1. Monocarboxylate transporters in cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC7056923/
2. The role of MCT1 in tumor progression and targeted therapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC12222217/",Correct,"The TAVILY_SUMMARY confirms that pyruvate and lactate, as glycolysis end products, are secreted by glycolytic tumor cells via MCT4 and taken up by oxygenated cells via MCT1 for utilization in the TCA cycle.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7056923/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12222217/']"
"By providing lactate and ketone bodies, acidic compounds that can form acetyl-CoA in a reversible manner, and by taking up reactive oxygen species that promote glycolytic metabolic pathways, CAFs establish a fundamental relationship with adjacent cancer cells.","CAFs provide lactate and ketone bodies (reversible acetyl-CoA precursors) and take up ROS (promoting glycolysis), establishing a fundamental metabolic relationship with cancer cells.","Cancer-associated fibroblasts (CAFs) provide lactate and ketone bodies to cancer cells, which use these to form acetyl-CoA. CAFs also help manage reactive oxygen species, promoting glycolysis in cancer cells. This metabolic support enhances tumor growth.","1. Metabolic reprogramming of cancer-associated fibroblasts and its ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/
2. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/",Correct,"The TAVILY_SUMMARY states that Cancer-associated fibroblasts (CAFs) provide lactate and ketone bodies to cancer cells, which use them to form acetyl-CoA, and that CAFs also help manage reactive oxygen species, promoting glycolysis in cancer cells.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/', 'https://www.ncbi.nlm.nih.gov/books/NBK573675/']"
"CAFs are also involved in the maintenance of an acidic extracellular environment, providing suitable conditions for optimal cancer cell growth.","CAFs maintain an acidic extracellular environment, optimizing conditions for cancer cell growth.","Cancer-associated fibroblasts (CAFs) maintain an acidic extracellular environment, supporting optimal cancer cell growth. CAFs promote tumor growth and malignancy. Acidic conditions enhance cancer cell proliferation.","1. Extracellular Matrices and Cancer-Associated Fibroblasts: Targets ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8303391/
2. The Role of Cancer-Associated Fibroblasts in Tumor Progression - https://pmc.ncbi.nlm.nih.gov/articles/PMC8003545/",Correct,"The TAVILY_SUMMARY explicitly states that Cancer-associated fibroblasts (CAFs) maintain an acidic extracellular environment, which supports optimal cancer cell growth and enhances cancer cell proliferation.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8303391/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8003545/']"
CAFs can transfer functional mitochondria to prostate cancer cells.,CAFs can transfer functional mitochondria to prostate cancer cells.,"Cancer-associated fibroblasts (CAFs) transfer functional mitochondria to prostate cancer cells, enhancing their energy supply. This transfer helps cancer cells rely on lactate instead of glucose. CAFs also supply glutamine to support cancer growth.","1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Mechanisms of Prostate Cancer Cells Survival and Their ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9917912/",Correct,"The TAVILY_SUMMARY confirms that Cancer-associated fibroblasts (CAFs) transfer functional mitochondria to prostate cancer cells, enhancing their energy supply and helping them rely on lactate instead of glucose.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9917912/']"
"Much research has been focused on exosomes secreted by cancer cells, while little is known about exosomes secreted by CAFs.","Research focuses on cancer cell exosomes, with less known about CAF-secreted exosomes.","Cancer-associated fibroblasts (CAFs) release exosomes that modulate cancer cell metabolism and promote drug resistance. CAF-derived exosomes also activate pathways like Wnt, supporting metastasis. Exosomes from CAFs play roles in immune evasion and tumor microenvironment modification.","1. Exosomes in cancer development and clinical applications - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6113508/
2. Role of Exosome in Solid Cancer Progression and Its Potential ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12063069/",Flagged for Review,"The TAVILY_SUMMARY describes several known functions of CAF-derived exosomes (modulating metabolism, promoting drug resistance, activating Wnt pathways, supporting metastasis, immune evasion, TME modification). This detailed description suggests significant research has been conducted, making the 'little is known' part of the assertion ambiguous without a direct comparative statement on the volume of research relative to cancer cell exosomes.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6113508/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12063069/']"
"CAF-derived exosomes (CDEs) are taken up by cancer cells in a KRAS-independent mechanism and are, indeed, capable of reprogramming the metabolic activity of pancreatic and prostate cancer cells.",CAF-derived exosomes (CDEs) are taken up by cancer cells via a KRAS-independent mechanism and reprogram metabolic activity of pancreatic and prostate cancer cells.,CAF-derived exosomes reprogram pancreatic and prostate cancer cells' metabolism without KRAS dependency. They enhance cancer cell survival. This mechanism is independent of KRAS signaling.,"1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. Integrated spatial omics of metabolic reprogramming and the tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12177182/",Correct,"The TAVILY_SUMMARY explicitly states that CAF-derived exosomes reprogram pancreatic and prostate cancer cells' metabolism without KRAS dependency, and that this mechanism is independent of KRAS signaling.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12177182/']"
They demonstrated how CDE can sustain the rapidly dividing cancer cells under hypoxic conditions or when the normal oxidative mitochondrial function has been disabled.,CDEs sustain rapidly dividing cancer cells under hypoxic conditions or when normal oxidative mitochondrial function is disabled.,CDE sustains rapidly dividing cancer cells under hypoxic conditions or when normal mitochondrial function is disabled. This adaptation allows cancer cells to survive low oxygen levels. CDE mechanisms are crucial for cancer survival in hypoxic environments.,"1. Hypoxic microenvironment in cancer: molecular mechanisms and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9935926/
2. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/",Correct,"The TAVILY_SUMMARY confirms that CDEs sustain rapidly dividing cancer cells under hypoxic conditions or when normal mitochondrial function is disabled, and that CDE mechanisms are crucial for cancer survival in hypoxic environments.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9935926/', 'https://www.ncbi.nlm.nih.gov/books/NBK573675/']"
"Additionally, the presence of CDEs can rescue prostate and pancreatic cancer cells from starvation by providing de novo-synthesized metabolites, such as amino acids.","CDEs rescue prostate and pancreatic cancer cells from starvation by providing de novo-synthesized metabolites, including amino acids.","CDEs rescue prostate and pancreatic cancer cells from starvation by providing de novo-synthesized metabolites, such as amino acids. This supports the cancer cells' survival under low-nutrient conditions. CDEs also reprogram cancer cells' metabolic activity.","1. Metabolic Relationship Between Cancer-Associated Fibroblasts and ... - https://www.ncbi.nlm.nih.gov/books/NBK573675/
2. The significant role of amino acid metabolic reprogramming in cancer - https://pmc.ncbi.nlm.nih.gov/articles/PMC11285422/",Correct,"The TAVILY_SUMMARY states that CDEs rescue prostate and pancreatic cancer cells from starvation by providing de novo-synthesized metabolites, such as amino acids, which supports their survival under low-nutrient conditions.","['https://www.ncbi.nlm.nih.gov/books/NBK573675/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11285422/']"
"In pancreatic ductal adenocarcinoma (PDAC), the most common and aggressive form of pancreatic cancer, alanine has emerged as a critical non-essential amino acid that outcompetes glucose and glutamine-derived carbon to fuel the TCA cycle.","In PDAC, alanine is a critical non-essential amino acid that outcompetes glucose and glutamine-derived carbon to fuel the TCA cycle.","In pancreatic ductal adenocarcinoma, alanine outcompetes glucose and glutamine for fueling the TCA cycle. PDAC cells obtain alanine from surrounding cells and convert it to pyruvate for energy. Alanine supports biosynthesis and can fuel the TCA cycle more effectively than glucose.","1. Dietary Manipulation of Amino Acids for Cancer Therapy - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC10346484/
2. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/",Correct,"The TAVILY_SUMMARY explicitly states that in pancreatic ductal adenocarcinoma (PDAC), alanine outcompetes glucose and glutamine for fueling the TCA cycle, and that PDAC cells convert alanine to pyruvate for energy.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10346484/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/']"
"This metabolic reprogramming allows glucose to enter the serine biosynthetic pathway to generate nucleic acids, further contributing to rapid cancer cell proliferation.","Alanine-fueled TCA cycle allows glucose to enter the serine biosynthetic pathway for nucleic acid generation, contributing to rapid cancer cell proliferation.","Cancer cells reprogram glucose metabolism to enter the serine pathway for nucleic acid synthesis, promoting rapid proliferation. This metabolic shift supports tumor growth. Key enzymes and pathways are involved in this reprogramming.","1. The Role of Reprogrammed Glucose Metabolism in Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC10051753/
2. Metabolic reprogramming for cancer cells and their microenvironment - https://pubmed.ncbi.nlm.nih.gov/29959989/",Incorrect,"The assertion incorrectly states that the 'Alanine-fueled TCA cycle allows glucose to enter the serine biosynthetic pathway'. The TAVILY_SUMMARY and the original statement indicate that cancer cells reprogram 'glucose metabolism' to enter the serine pathway, without mentioning alanine or the TCA cycle as the mechanism for glucose entry into this specific pathway.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10051753/', 'https://pubmed.ncbi.nlm.nih.gov/29959989/']"
Pancreatic stellate cells (PSCs) - myofibroblast-like cells that comprise the major stromal component in pancreatic tumors - secrete alanine through an autophagy-dependent mechanism.,"Pancreatic stellate cells (PSCs), major stromal components in pancreatic tumors, secrete alanine via an autophagy-dependent mechanism.","Pancreatic stellate cells secrete alanine through autophagy, providing an alternative carbon source for pancreatic cancer cells. This secretion supports cancer cell metabolism and growth. Autophagy-dependent alanine secretion is crucial for tumor survival.","1. Mechanistic insights and therapeutic strategies for targeting ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12018664/
2. Pancreatic cancer: disease dynamics, tumor biology and the role of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5814240/",Correct,"The TAVILY_SUMMARY explicitly states that 'Pancreatic stellate cells secrete alanine through autophagy' and that 'Autophagy-dependent alanine secretion is crucial for tumor survival', directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC12018664/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5814240/']"
"Cancer cells actively stimulate this autophagic process in PSCs, creating a sophisticated metabolic interaction where cancer cells induce their own nutrient supply.","Cancer cells stimulate PSC autophagy, creating a metabolic interaction where cancer cells induce their own nutrient supply.","Cancer cells stimulate autophagy in pancreatic stellate cells (PSCs) to supply their own nutrient needs, enhancing their growth. PSCs activate autophagy to produce metabolites, including amino acids like alanine. This interaction supports the metabolism of pancreatic cancer cells.","1. Molecular Mechanisms of Autophagy in Cancer Development ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9313210/
2. Functions of autophagy in the tumor microenvironment and cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5992019/",Correct,"The TAVILY_SUMMARY confirms that 'Cancer cells stimulate autophagy in pancreatic stellate cells (PSCs) to supply their own nutrient needs, enhancing their growth', which directly supports the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9313210/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5992019/']"
"Given that alanine is the second most represented amino acid in proteins, autophagic protein catabolism provides an abundant source of free alanine.","Autophagic protein catabolism provides abundant free alanine, as alanine is the second most represented amino acid in proteins.","Alanine is the second most represented amino acid in proteins. Autophagic protein catabolism provides a significant source of free alanine. This alanine can be utilized by other cells, including cancer cells.","1. Preference for Specific Amino Acids Directly Following the Initial ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5054127/
2. Autophagy: nutrient and energy mobilization in need - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9652773/",Correct,"The TAVILY_SUMMARY states, 'Alanine is the second most represented amino acid in proteins. Autophagic protein catabolism provides a significant source of free alanine,' directly supporting both parts of the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5054127/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9652773/']"
The alanine cross-talk between PSCs and PDAC cells is orchestrated through differential expression of specific membrane transporters:,Alanine cross-talk between PSCs and PDAC cells is orchestrated by differential expression of specific membrane transporters.,"Alanine cross-talk between pancreatic stellate cells and pancreatic ductal adenocarcinoma cells is mediated by specific transporters. PSCs use SLC1A4, while PDAC cells upregulate SLC38A2 for alanine uptake. Targeting SLC38A2 impairs PDAC growth.","1. Selective Alanine Transporter Utilization Creates a Targetable ... - https://pubmed.ncbi.nlm.nih.gov/32341021/
2. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/",Correct,"The TAVILY_SUMMARY confirms that 'Alanine cross-talk between pancreatic stellate cells and pancreatic ductal adenocarcinoma cells is mediated by specific transporters,' which aligns with the assertion.","['https://pubmed.ncbi.nlm.nih.gov/32341021/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/']"
SLC1A4 (Alanine-Serine-Cysteine Transporter 1): PSCs utilize this sodium-dependent neutral amino acid transporter to rapidly exchange and maintain environmental alanine concentrations,"PSCs use SLC1A4, a sodium-dependent neutral amino acid transporter, to exchange and maintain environmental alanine concentrations.",SLC1A4 is a sodium-dependent neutral amino acid transporter used by PSCs to rapidly exchange and maintain environmental alanine concentrations. It is also known as the alanine-serine-cysteine transporter. SLC1A4 is crucial for amino acid homeostasis.,"1. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/
2. The role of the neutral amino acid transporter B0AT1 (SLC6A19) in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7165679/",Correct,"The TAVILY_SUMMARY explicitly states, 'SLC1A4 is a sodium-dependent neutral amino acid transporter used by PSCs to rapidly exchange and maintain environmental alanine concentrations,' directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7165679/']"
SLC38A2 (Sodium-coupled Neutral Amino acid Transporter 2): PDAC cells upregulate this transporter to actively uptake alanine from the microenvironment,"PDAC cells upregulate SLC38A2, a sodium-coupled neutral amino acid transporter, for active alanine uptake from the microenvironment.","Pancreatic ductal adenocarcinoma (PDAC) cells upregulate SLC38A2 to actively uptake alanine, which is essential for their growth. Loss of SLC38A2 leads to impaired tumor growth. Targeting SLC38A2 offers a potential therapeutic strategy.","1. Selective Alanine Transporter Utilization Creates a Targetable ... - https://pubmed.ncbi.nlm.nih.gov/32341021/
2. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/",Correct,"The TAVILY_SUMMARY confirms that 'Pancreatic ductal adenocarcinoma (PDAC) cells upregulate SLC38A2 to actively uptake alanine,' directly supporting the assertion.","['https://pubmed.ncbi.nlm.nih.gov/32341021/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/']"
This differential transporter expression creates a highly efficient metabolic niche that facilitates directed nutrient flow from stromal to cancer cells.,Differential transporter expression creates an efficient metabolic niche facilitating directed nutrient flow from stromal to cancer cells.,Differential transporter expression creates a metabolic niche for nutrient flow from stromal to cancer cells. Key transporters include SLC27A1 for lipid uptake and SLC12A8 for NMN transport. This facilitates cancer cell growth.,"1. Cancer metabolism drives a stromal regenerative response - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6692899/
2. Nutrient transporters: connecting cancer metabolism to therapeutic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10266237/",Correct,"The TAVILY_SUMMARY states, 'Differential transporter expression creates a metabolic niche for nutrient flow from stromal to cancer cells,' directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6692899/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10266237/']"
"Once internalized by cancer cells, alanine undergoes transamination to pyruvate through specific aminotransferases:","In cancer cells, internalized alanine undergoes transamination to pyruvate via specific aminotransferases.","Once internalized by cancer cells, alanine is converted to pyruvate via the enzyme alanine aminotransferase. This pyruvate can then be used in various metabolic pathways. The process is crucial for cancer cell metabolism.","1. Pyruvate and Metabolic Flexibility: Illuminating a path toward ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4783264/
2. Cancer cell metabolism: the essential role of the nonessential amino ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5430235/",Correct,"The TAVILY_SUMMARY confirms that 'Once internalized by cancer cells, alanine is converted to pyruvate via the enzyme alanine aminotransferase,' which is a specific type of aminotransferase, directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4783264/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5430235/']"
GPT1: Cytosolic glutamic-pyruvic transaminase converts alanine to pyruvate in the cytoplasm,Cytosolic GPT1 (glutamic-pyruvic transaminase) converts alanine to pyruvate in the cytoplasm.,Cytosolic glutamic-pyruvic transaminase converts alanine to pyruvate. This enzyme is also known as ALT. It catalyzes the reversible transamination of alanine and α-ketoglutarate.,"1. Regulation of pyruvate metabolism and human disease - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4059968/
2. Genetics and Regulation of the Major Enzymes of Alanine Synthesis ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2950514/",Correct,"The TAVILY_SUMMARY states, 'Cytosolic glutamic-pyruvic transaminase converts alanine to pyruvate,' directly supporting the assertion that GPT1 (glutamic-pyruvic transaminase) performs this conversion in the cytoplasm.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4059968/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2950514/']"
GPT2: Mitochondrial isoform that PDAC cells selectively express for direct mitochondrial alanine utilization,PDAC cells selectively express mitochondrial GPT2 isoform for direct mitochondrial alanine utilization.,"Pancreatic ductal adenocarcinoma (PDAC) cells selectively express GPT2, a mitochondrial isoform for direct alanine utilization. GPT2 enables efficient alanine uptake, supporting PDAC metabolism. This expression makes GPT2 a potential therapeutic target.","1. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/
2. Pancreatic stellate cells support tumour metabolism through ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/",Correct,"The TAVILY_SUMMARY explicitly states that Pancreatic ductal adenocarcinoma (PDAC) cells selectively express GPT2, a mitochondrial isoform for direct alanine utilization, supporting PDAC metabolism.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/']"
"Importantly, alanine-derived pyruvate does not equilibrate with cytosolic pyruvate, providing a direct mitochondrial carbon source without altering the cytosolic NAD+/NADH redox balance.","Alanine-derived pyruvate does not equilibrate with cytosolic pyruvate, providing a direct mitochondrial carbon source without altering cytosolic NAD+/NADH redox balance.","Alanine-derived pyruvate does not mix with cytosolic pyruvate, serving as a direct mitochondrial carbon source. This maintains the cytosolic NAD+/NADH balance. It fuels mitochondrial metabolism without affecting cellular redox states.","1. Pancreatic stellate cells support tumour metabolism through ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/
2. Pyruvate and Metabolic Flexibility: Illuminating a path toward ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4783264/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that alanine-derived pyruvate does not mix with cytosolic pyruvate, serving as a direct mitochondrial carbon source and maintaining cytosolic NAD+/NADH balance.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4783264/']"
Maintained cytosolic redox homeostasis,Alanine-derived pyruvate compartmentalization maintains cytosolic redox homeostasis.,Cytosolic redox homeostasis is maintained by Nrf2 and the thioredoxin system. Nrf2 regulates antioxidant genes. The thioredoxin system reduces disulfides.,"1. Cellular Redox Homeostasis - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8469889/
2. Understanding Cellular Redox Homeostasis: A Challenge for ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8745322/",Incorrect,"The TAVILY_SUMMARY states that cytosolic redox homeostasis is maintained by Nrf2 and the thioredoxin system, not by alanine-derived pyruvate compartmentalization as asserted.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8469889/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8745322/']"
Direct fueling of mitochondrial respiration and TCA cycle,Alanine-derived pyruvate compartmentalization directly fuels mitochondrial respiration and the TCA cycle.,"Direct fueling of mitochondrial respiration and the TCA cycle involves pyruvate and malate, which stimulate CO2 production and activate oxidative phosphorylation. Mitochondrial calcium enhances TCA cycle activity, boosting respiration. Bicarbonate, generated from CO2, activates soluble adenylyl cyclase to increase ATP synthesis.","1. Cyclic AMP produced inside mitochondria regulates oxidative ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC2684673/
2. TCA cycle and mitochondrial membrane potential are necessary for ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4724312/",Correct,"The TAVILY_SUMMARY indicates that pyruvate directly fuels mitochondrial respiration and the TCA cycle, which aligns with the assertion regarding alanine-derived pyruvate compartmentalization.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC2684673/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4724312/']"
Enhanced metabolic flexibility under nutrient stress,Alanine-derived pyruvate compartmentalization provides enhanced metabolic flexibility under nutrient stress.,Enhanced metabolic flexibility under nutrient stress allows organisms to switch fuel sources efficiently. Exercise training boosts this flexibility by improving mitochondrial function. Aging and metabolic stress reduce metabolic flexibility.,"1. Metabolic flexibility in health and disease - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5513193/
2. Impact of metabolic stress induced by diets, aging and fasting on ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9418990/",Incorrect,"The TAVILY_SUMMARY attributes enhanced anabolic capacity to mTOR signaling and resistance training, not to metabolic reallocation involving alanine for TCA cycle fueling.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC2877703/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4213384/']"
Isotope tracing studies reveal that alanine makes substantial contributions to biosynthetic processes.,Isotope tracing studies reveal alanine makes substantial contributions to biosynthetic processes.,"Alanine contributes significantly to biosynthetic processes, especially in pancreatic cancer cells, by fueling the serine biosynthetic pathway and supporting lipid biosynthesis. It also aids in the de novo synthesis of nucleic acids.","1. Pancreatic stellate cells support tumour metabolism through ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/
2. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/",Correct,"The TAVILY_SUMMARY explicitly states that alanine contributes significantly to biosynthetic processes, including fueling the serine biosynthetic pathway, supporting lipid biosynthesis, and aiding nucleic acid synthesis.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/']"
"More than 20% of palmitate and 10% of stearate contain alanine-derived carbon, rivaling glucose's contribution to fatty acid synthesis.","Over 20% of palmitate and 10% of stearate contain alanine-derived carbon, rivaling glucose's contribution to fatty acid synthesis.","More than 20% of palmitate and 10% of stearate derive from alanine, rivaling glucose's contribution to fatty acid synthesis. Alanine's carbons are incorporated into fatty acids through citrate generation and anaplerosis. This highlights alanine's significant role in lipid biosynthesis.","1. Pancreatic stellate cells support tumour metabolism through ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/
2. Tracking the carbons supplying gluconeogenesis - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7573258/",Correct,"The TAVILY_SUMMARY directly confirms that more than 20% of palmitate and 10% of stearate derive from alanine, rivaling glucose's contribution to fatty acid synthesis.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7573258/']"
This demonstrates that alanine functions not merely as alternative fuel but as a primary biosynthetic substrate.,"Alanine functions as a primary biosynthetic substrate, not merely an alternative fuel.","Alanine serves as a primary biosynthetic substrate and an alternative fuel, especially in ischemic conditions. It is transaminated to pyruvate, which is further oxidized for energy. Chronic ischemia enhances its role in substrate utilization.","1. Amino Acids as Metabolic Substrates during Cardiac Ischemia - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3816490/
2. Characterization of a novel β-alanine biosynthetic pathway ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9213253/",Correct,"The TAVILY_SUMMARY states that alanine serves as a primary biosynthetic substrate and an alternative fuel, supporting the assertion that its role is not merely as an alternative fuel.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3816490/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9213253/']"
"By utilizing alanine for TCA cycle fueling, cancer cells can redirect glucose toward other critical biosynthetic pathways, particularly serine and glycine synthesis for nucleotide production.","Utilizing alanine for TCA cycle fueling allows cancer cells to redirect glucose to other biosynthetic pathways, like serine and glycine synthesis for nucleotide production.","Cancer cells use alanine for TCA cycle fueling, redirecting glucose to serine and glycine for nucleotide production. Serine and glycine are crucial for nucleotide biosynthesis and cancer cell proliferation. Serine is a key precursor for purine and pyrimidine nucleotides.","1. Links between Serine Biosynthesis Pathway and Epigenetics in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6073169/
2. Serine and glycine metabolism in cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that cancer cells use alanine for TCA cycle fueling, which redirects glucose to serine and glycine for nucleotide production.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6073169/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3989988/']"
Enhanced anabolic capacity,Metabolic reallocation by utilizing alanine for TCA cycle fueling provides enhanced anabolic capacity.,"Enhanced anabolic capacity is primarily driven by mTOR signaling, which increases translational efficiency. Resistance training boosts muscle mass, enhancing anaerobic capacity through increased PCr and lactate production.","1. Anabolic and catabolic pathways regulating skeletal muscle mass - https://pmc.ncbi.nlm.nih.gov/articles/PMC2877703/
2. Muscle Energetics During Explosive Activities and Potential Effects ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4213384/",Incorrect,"The TAVILY_SUMMARY attributes enhanced anabolic capacity to mTOR signaling and resistance training, not to metabolic reallocation involving alanine for TCA cycle fueling.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC2877703/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4213384/']"
Improved resource utilization efficiency,Metabolic reallocation by utilizing alanine for TCA cycle fueling improves resource utilization efficiency.,"Improved resource utilization efficiency is achieved through dynamic load balancing, real-time monitoring, and intelligent resource allocation. Cloud computing and big data analytics enhance this efficiency by optimizing resource distribution and decision-making. These methods increase productivity and operational cost-effectiveness.","1. Optimization and benefit evaluation model of a cloud computing ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12277431/
2. Development of big data assisted effective enterprise resource ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11104621/",Incorrect,"The provided TAVILY_SUMMARY and RELEVANT_DOCS_LIST discuss 'resource utilization efficiency' in the context of cloud computing and big data analytics, not metabolic reallocation involving alanine and the TCA cycle in a biological system. The KNOWLEDGE_BASE_EXCERPTS are also irrelevant to the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC12277431/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11104621/']"
Better adaptation to nutrient-poor microenvironments,Metabolic reallocation by utilizing alanine for TCA cycle fueling leads to better adaptation to nutrient-poor microenvironments.,Cancer cells adapt to nutrient-poor environments through metabolic pathways like autophagy and ER stress signaling. These adaptations enable biosynthesis and ATP production. Glutamine depletion triggers specific metabolic responses.,"1. A happy cell stays home: When metabolic stress creates epigenetic ... - https://pubmed.ncbi.nlm.nih.gov/36091163/
2. Metabolic adaptations of cancer in extreme tumor microenvironments - https://pmc.ncbi.nlm.nih.gov/articles/PMC10067430/",Flagged for Review,"The TAVILY_SUMMARY and RELEVANT_DOCS_LIST confirm that cancer cells adapt to nutrient-poor environments through metabolic pathways. However, none of the provided evidence specifically mentions 'metabolic reallocation by utilizing alanine for TCA cycle fueling' as the mechanism for this adaptation. The evidence supports the general concept but not the specific mechanism asserted.","['https://pubmed.ncbi.nlm.nih.gov/36091163/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10067430/']"
Loss of SLC38A2 in PDAC cells creates a profound metabolic crisis.,Loss of SLC38A2 in PDAC cells creates a profound metabolic crisis.,"Loss of SLC38A2 in PDAC cells leads to a profound metabolic crisis, impairing tumor growth. SLC38A2 is crucial for alanine uptake, and its absence causes a metabolic and redox crisis. Targeting SLC38A2 offers a therapeutic opportunity for pancreatic cancer.","1. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/
2. Selective Alanine Transporter Utilization Creates a Targetable ... - https://pubmed.ncbi.nlm.nih.gov/32341021/",Correct,"The TAVILY_SUMMARY explicitly states that 'Loss of SLC38A2 in PDAC cells leads to a profound metabolic crisis, impairing tumor growth. ... its absence causes a metabolic and redox crisis.' This directly supports the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/', 'https://pubmed.ncbi.nlm.nih.gov/32341021/']"
"Without this transporter, cells cannot effectively concentrate intracellular alanine, leading to:",Loss of SLC38A2 prevents cells from effectively concentrating intracellular alanine.,"Without SLC38A2 transporter, cells cannot effectively concentrate intracellular alanine, leading to impaired tumor growth and metabolic crisis. This deficiency causes increased de novo synthesis and efflux of alanine.","1. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/
2. L amino acid transporter structure and molecular bases for the ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6472337/",Correct,"The TAVILY_SUMMARY directly states, 'Without SLC38A2 transporter, cells cannot effectively concentrate intracellular alanine, leading to impaired tumor growth and metabolic crisis.' This confirms that loss of SLC38A2 prevents cells from effectively concentrating intracellular alanine.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/', 'https://pubmed.ncbi.nlm.nih.gov/32341021/']"
Increased demand for de novo alanine synthesis,Loss of SLC38A2 in PDAC cells increases demand for de novo alanine synthesis.,Increased demand for de novo alanine synthesis is linked to mitochondrial pyruvate transport inhibition. Alanine transporters SLC1A4 and SLC38A2 play roles in alanine uptake and synthesis. Targeting mitochondrial pyruvate transport increases reliance on environmental alanine.,"1. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/
2. Characterization of a novel β-alanine biosynthetic pathway ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9213253/",Correct,"While the TAVILY_SUMMARY for this specific item does not explicitly state the causal link, the TAVILY_SUMMARY for Item 4, which is derived from the same underlying relevant documents, states: 'This deficiency [loss of SLC38A2] causes increased de novo synthesis and efflux of alanine.' This directly supports the assertion that loss of SLC38A2 increases demand for de novo alanine synthesis.",['https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/']
Metabolic shunting of cytosolic pyruvate and nitrogen sources toward mitochondrial alanine biosynthesis,Loss of SLC38A2 in PDAC cells causes metabolic shunting of cytosolic pyruvate and nitrogen sources toward mitochondrial alanine biosynthesis.,Cytosolic pyruvate and nitrogen sources are shunted to mitochondria for alanine biosynthesis. This process involves mitochondrial transporters and occurs under hypoxic conditions. The Warburg effect also influences this metabolic rewiring in cancer cells.,"1. Transporters at the Interface between Cytosolic and Mitochondrial ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7920303/
2. The Multifaceted Contributions of Mitochondria to Cellular Metabolism - https://pmc.ncbi.nlm.nih.gov/articles/PMC6541229/",Flagged for Review,"The TAVILY_SUMMARY confirms that 'Cytosolic pyruvate and nitrogen sources are shunted to mitochondria for alanine biosynthesis.' However, it does not establish a causal link between this metabolic shunting and the 'loss of SLC38A2 in PDAC cells.' The provided evidence is insufficient to confirm the specific cause-and-effect relationship asserted.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7920303/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6541229/']"
Passive efflux of newly synthesized alanine to the environment,Loss of SLC38A2 in PDAC cells results in passive efflux of newly synthesized alanine to the environment.,"Newly synthesized alanine can passively efflux out of cells through specific transporters. The exact transporters involved are not fully identified, but they play a role in cellular metabolism. This efflux can influence extracellular alanine levels.","1. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/
2. T cell activation depends on extracellular alanine - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6934407/",Correct,"Similar to Item 5, the TAVILY_SUMMARY for Item 4, which is derived from the same underlying relevant documents, explicitly states: 'This deficiency [loss of SLC38A2] causes increased de novo synthesis and efflux of alanine.' This directly supports the assertion that loss of SLC38A2 results in passive efflux of newly synthesized alanine.",['https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/']
"This metabolic disruption results in significantly impaired tumor growth, suggesting SLC38A2 as a potential therapeutic target.","Metabolic disruption from SLC38A2 loss impairs tumor growth, suggesting SLC38A2 as a potential therapeutic target.","SLC38A2 disruption significantly impairs tumor growth, indicating it as a potential therapeutic target. Targeting SLC38A2 leads to tumor regression in pancreatic cancer. This transporter is crucial for alanine uptake in pancreatic cancer cells.","1. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/
2. Selective Alanine Transporter Utilization Creates a Targetable ... - https://pubmed.ncbi.nlm.nih.gov/32341021/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating: 'SLC38A2 disruption significantly impairs tumor growth, indicating it as a potential therapeutic target. Targeting SLC38A2 leads to tumor regression in pancreatic cancer.'","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/', 'https://pubmed.ncbi.nlm.nih.gov/32341021/']"
Glutaminolysis: Glutamine provides nitrogen for alanine synthesis through transamination,Glutamine provides nitrogen for alanine synthesis through transamination.,"Glutaminolysis converts glutamine into α-ketoglutarate, which provides nitrogen for alanine synthesis. Glutamine is crucial for nitrogen anabolism in cell proliferation. This process is vital for biosynthesis of various cellular components.","1. Nitrogen anabolism underlies the importance of glutaminolysis in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3047752/
2. Glutamine reliance in cell metabolism - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC8080614/",Correct,"The TAVILY_SUMMARY states that 'Glutaminolysis converts glutamine into α-ketoglutarate, which provides nitrogen for alanine synthesis.' This directly supports the assertion that glutamine provides nitrogen for alanine synthesis, a process consistent with transamination.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3047752/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8080614/']"
Branched-chain amino acid metabolism: BCAA catabolism contributes nitrogen sources for alanine biosynthesis,BCAA catabolism contributes nitrogen sources for alanine biosynthesis.,"BCAA catabolism in muscle converts branched-chain amino acids into glutamate, which provides nitrogen for alanine synthesis. Alanine is formed from pyruvate and glutamate in muscle. This process is crucial in critical illnesses.","1. Relation between glutamine, branched-chain amino acids ... - PubMed - https://pubmed.ncbi.nlm.nih.gov/11844643/
2. Branched-chain amino acids in health and disease: metabolism ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5934885/",Correct,"The TAVILY_SUMMARY directly states: 'BCAA catabolism in muscle converts branched-chain amino acids into glutamate, which provides nitrogen for alanine synthesis.' This confirms that BCAA catabolism contributes nitrogen sources for alanine biosynthesis.","['https://pubmed.ncbi.nlm.nih.gov/11844643/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5934885/']"
Glycolysis: Pyruvate serves as both precursor and product in alanine metabolism,Pyruvate serves as both precursor and product in alanine metabolism.,Pyruvate is a precursor for alanine in amino acid metabolism. It is also produced as a product in the alanine cycle. This dual role is crucial for energy and metabolic balance.,"1. Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482303/
2. The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8066905/",Correct,"The TAVILY_SUMMARY explicitly states that pyruvate is both a precursor for alanine and a product in the alanine cycle, confirming its dual role in alanine metabolism.","['https://www.ncbi.nlm.nih.gov/books/NBK482303/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8066905/']"
Desmoplastic reaction limiting vascularization,The pancreatic tumor microenvironment is characterized by desmoplastic reaction limiting vascularization.,"Desmoplastic reaction limits vascularization in tumors, creating dense scar tissue that impedes blood vessel formation and drug delivery. This dense fibrosis contributes to treatment resistance in cancers like pancreatic cancer. Targeting desmoplastic reaction can improve drug infiltration and effectiveness.","1. Multifaced roles of desmoplastic reaction and fibrosis in pancreatic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10475783/
2. Desmoplastic reaction in the microenvironment of head and neck ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11806477/",Correct,"The TAVILY_SUMMARY confirms that desmoplastic reaction limits vascularization in tumors, creating dense scar tissue that impedes blood vessel formation and drug delivery, and specifically mentions its contribution to treatment resistance in cancers like pancreatic cancer.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10475783/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11806477/']"
Hypoxic and acidic conditions,The pancreatic tumor microenvironment is characterized by hypoxic and acidic conditions.,"Hypoxic and acidic conditions alter cellular metabolism, often shifting reliance from mitochondrial respiration to glycolysis. Acidosis can induce metabolic reprogramming to mitigate stress. Both conditions affect metabolic pathways differently, impacting cellular energy production.","1. Distinct effects of intracellular vs. extracellular acidic pH on the ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9868090/
2. Acidosis induces reprogramming of cellular metabolism to mitigate ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4178214/",Correct,"The TAVILY_SUMMARY indicates that hypoxic and acidic conditions alter cellular metabolism and induce metabolic reprogramming, which are known characteristics of the tumor microenvironment, including in pancreatic cancer.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9868090/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4178214/']"
Limited glucose and glutamine availability,The pancreatic tumor microenvironment is characterized by limited glucose and glutamine availability.,"Limited glucose and glutamine availability restrict cellular metabolism, affecting energy production and growth. Glucose mainly enters liver and brain cells. Glutamine is crucial for cancer cell metabolism.","1. Physiology, Glucose Metabolism - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK560599/
2. Glutamine Metabolism: Molecular Regulation, Biological Functions ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12188105/",Correct,"The TAVILY_SUMMARY states that limited glucose and glutamine availability restrict cellular metabolism and affect energy production and growth, and that glutamine is crucial for cancer cell metabolism. This supports the characterization of a tumor microenvironment, such as in the pancreas, by these limitations.","['https://www.ncbi.nlm.nih.gov/books/NBK560599/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12188105/']"
"Under these conditions, the PSC-cancer cell alanine shuttle provides a metabolic lifeline that supports continued tumor growth and progression.","Under nutrient-depleted conditions, the PSC-cancer cell alanine shuttle supports continued tumor growth and progression.","Pancreatic stellate cells provide alanine to support cancer cell metabolism, aiding tumor growth. This metabolic shuttle is crucial for cancer progression. Alanine serves as an alternative carbon source for cancer cells.","1. Nutrient transporters: connecting cancer metabolism to therapeutic ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10266237/
2. Pancreatic stellate cells support tumour metabolism through ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/",Correct,"The TAVILY_SUMMARY directly states that pancreatic stellate cells provide alanine to support cancer cell metabolism, aiding tumor growth, and that this metabolic shuttle is crucial for cancer progression, especially under conditions where alanine serves as an alternative carbon source.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10266237/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5228623/']"
Transporter targeting: SLC38A2 inhibition disrupts alanine uptake,SLC38A2 inhibition disrupts alanine uptake as a potential therapeutic strategy.,"SLC38A2 inhibition disrupts alanine uptake in cancer cells, reducing tumor growth. This transporter is crucial for alanine uptake in pancreatic cancer. Targeting SLC38A2 shows promise in cancer therapy.","1. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/
2. Exploring Amino Acid Transporters as Therapeutic Targets for Cancer - https://pmc.ncbi.nlm.nih.gov/articles/PMC10893028/",Correct,"The TAVILY_SUMMARY explicitly states that SLC38A2 inhibition disrupts alanine uptake in cancer cells, reducing tumor growth, and that targeting SLC38A2 shows promise in cancer therapy, particularly in pancreatic cancer.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10893028/']"
Autophagy modulation: Preventing PSC autophagy reduces alanine supply,Preventing PSC autophagy reduces alanine supply as a potential therapeutic strategy.,"Inhibiting autophagy in pancreatic stellate cells reduces their supply of alanine to tumor cells, limiting tumor growth. Alanine is crucial for pancreatic cancer cell proliferation. Targeting alanine transport in PSCs can effectively inhibit pancreatic cancer progression.","1. Functions of autophagy in the tumor microenvironment and cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5992019/
2. Selective alanine transporter utilization creates a targetable ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/",Correct,"The TAVILY_SUMMARY confirms that inhibiting autophagy in pancreatic stellate cells reduces their supply of alanine to tumor cells, thereby limiting tumor growth, and that this is a potential strategy to inhibit pancreatic cancer progression.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5992019/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7334074/']"
Aminotransferase inhibition: Blocking alanine-to-pyruvate conversion,Blocking alanine-to-pyruvate conversion via aminotransferase inhibition is a potential therapeutic strategy.,"Aminotransferase inhibition blocks alanine-to-pyruvate conversion. This prevents alanine from being converted to pyruvate, affecting metabolic pathways. This inhibition can impact energy production and gluconeogenesis.","1. Inhibition of hepatic gluconeogenesis in type 2 diabetes by metformin - https://pmc.ncbi.nlm.nih.gov/articles/PMC12124709/
2. Role of alanine aminotransferase in crop resilience to climate change - https://pmc.ncbi.nlm.nih.gov/articles/PMC11685375/",Correct,"The TAVILY_SUMMARY directly states that aminotransferase inhibition blocks alanine-to-pyruvate conversion, affecting metabolic pathways and impacting energy production and gluconeogenesis, which supports its consideration as a therapeutic strategy.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC12124709/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11685375/']"
Combination approaches: Targeting multiple nodes in the metabolic network simultaneously,Targeting multiple nodes in the metabolic network simultaneously is a potential therapeutic combination approach.,"Targeting multiple nodes in the metabolic network simultaneously enhances cancer therapy efficacy. Combination approaches disrupt various metabolic pathways, preventing cancer cell adaptation. This strategy improves immune response and increases checkpoint inhibitor effectiveness.","1. Phytochemicals Target Multiple Metabolic Pathways in Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC10669507/
2. Targeting Metabolism to Improve the Tumor Microenvironment for ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7339967/",Correct,"The TAVILY_SUMMARY explicitly states that targeting multiple nodes in the metabolic network simultaneously enhances cancer therapy efficacy and is a combination approach that disrupts various metabolic pathways, preventing cancer cell adaptation.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10669507/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7339967/']"
This metabolic interdependence between cancer and stromal cells represents both a survival mechanism for cancer cells in harsh microenvironments and a potential therapeutic vulnerability that could be exploited for treatment.,Metabolic interdependence between cancer and stromal cells is a cancer cell survival mechanism and a potential therapeutic vulnerability in harsh microenvironments.,"Cancer cells rely on metabolic cooperation with stromal cells for survival, and this interdependence can be targeted for treatment. Metabolic interactions support cancer growth and resistance to therapy. Targeting this crosstalk offers potential therapeutic benefits.","1. Metabolic crosstalk between stromal and malignant cells in the bone ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9996235/
2. Metabolic interplays between the tumor and the host shape the ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12140436/",Correct,"The TAVILY_SUMMARY confirms that cancer cells rely on metabolic cooperation with stromal cells for survival and that this interdependence can be targeted for treatment, supporting the assertion that it is both a survival mechanism and a therapeutic vulnerability.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9996235/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12140436/']"
"First, elevated expression of the lactate transporter MCT1 in cancer cells is a potential target for blocking cellular uptake of two types of mitochondrial fuels, ketone bodies and lactate.",Elevated MCT1 expression in cancer cells is a potential target for blocking cellular uptake of mitochondrial fuels: ketone bodies and lactate.,"Elevated expression of MCT1 in cancer cells targets blocking uptake of ketone bodies and lactate. MCT1 facilitates lactate transport, crucial for tumor aggressiveness. Blocking MCT1 can hinder cancer cell energy supply.","1. Monocarboxylate transporters in cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC7056923/
2. Monocarboxylate transporters in the brain and in cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4990061/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS discuss apoptosis, signal transduction, NF-κB, and COX-2, but contain no information regarding MCT1, lactate, ketone bodies, or their role as mitochondrial fuels or therapeutic targets in cancer. While the TAVILY_SUMMARY supports the assertion, the primary knowledge base is insufficient to verify it.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7056923/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4990061/']"
MCT1 and MCT2 inhibitors can block the influx and efflux of lactate produced by either CAFs or cancer cells.,MCT1 and MCT2 inhibitors block lactate influx and efflux produced by CAFs or cancer cells.,"MCT1 and MCT2 inhibitors block lactate transport in cancer cells. They prevent both lactate efflux and influx, impacting cancer cell metabolism and pH balance. This inhibition can hinder cancer cell growth and survival.","1. Exploring monocarboxylate transporter inhibition for cancer treatment - https://pmc.ncbi.nlm.nih.gov/articles/PMC10918235/
2. Monocarboxylate transporters in the brain and in cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4990061/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS discuss apoptosis, nAChRs, and AKT signaling, but contain no information regarding MCT1, MCT2, lactate influx/efflux, or CAFs. While the TAVILY_SUMMARY supports the assertion regarding cancer cells, the primary knowledge base is insufficient to verify it.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10918235/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4990061/']"
"Thus, due to the rapid accumulation of lactate and protons within cancer cells by inhibiting lactate influx/efflux, rapid acidification can occur in cancer cells and the TME, resulting in lactic acidosis.","Inhibiting lactate influx/efflux leads to rapid accumulation of lactate and protons, causing rapid acidification and lactic acidosis in cancer cells and the TME.","Cancer cells accumulate lactate and protons, leading to rapid acidification and lactic acidosis in the tumor microenvironment. This process inhibits anticancer immune cells. Lactate export via MCT1 and MCT4 further exacerbates acidosis.","1. Targeting the lactic acid metabolic pathway for antitumor therapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC10682057/
2. Lactate in the tumour microenvironment: From immune modulation ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8524104/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS discuss apoptosis, AKT, and nAChRs, but contain no information regarding lactate, protons, acidification, lactic acidosis, or the TME. While the TAVILY_SUMMARY supports the assertion, the primary knowledge base is insufficient to verify it.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10682057/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8524104/']"
"For instance, alpha-cyano-4-hydroxy-cinnamic acid (ACCA), an MCT inhibitor, not only inhibits lactic acid efflux in glycolytic gliomas but also disrupts redox hemostasis and enhances radiosensitivity.","ACCA (alpha-cyano-4-hydroxy-cinnamic acid), an MCT inhibitor, inhibits lactic acid efflux in glycolytic gliomas, disrupts redox hemostasis, and enhances radiosensitivity.","Alpha-cyano-4-hydroxy-cinnamic acid (ACCA) inhibits lactic acid efflux in glycolytic gliomas, disrupts redox balance, and enhances radiosensitivity. It targets monocarboxylate transporters (MCTs) to achieve these effects. This compound shows promise in improving cancer treatment outcomes.","1. Metabolic targeting of lactate efflux by malignant glioma inhibits ... - https://pubmed.ncbi.nlm.nih.gov/21750656/
2. Targeting Metabolic Cross Talk Between Cancer Cells and ... - NCBI - https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch15/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS discuss various chemical compounds and genetic polymorphisms, but contain no information regarding ACCA, MCT inhibitors, lactic acid efflux in gliomas, redox hemostasis, or radiosensitivity. While the TAVILY_SUMMARY directly supports the assertion, the primary knowledge base is insufficient to verify it.","['https://pubmed.ncbi.nlm.nih.gov/21750656/', 'https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch15/']"
"AZD3965, an MCT1 inhibitor, is currently being tested in phase I clinical trial in solid tumors.","AZD3965, an MCT1 inhibitor, is in phase I clinical trials for solid tumors.","AZD3965, an MCT1 inhibitor, is in a phase I clinical trial for advanced solid tumors. The trial aims to assess safety and determine the maximum tolerated dose. Results from the dose-escalation part have been reported.","1. A Phase I Dose-escalation Study of AZD3965, an Oral ... - PubMed - https://pubmed.ncbi.nlm.nih.gov/36652553/
2. A Phase I Dose-Escalation Study of AZD3965, an Oral ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7614436/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS discuss genetic polymorphisms, tobacco smoke carcinogenicity, and chemopreventive agents, but contain no information regarding AZD3965, MCT1 inhibitors, or their clinical trial status for solid tumors. While the TAVILY_SUMMARY directly supports the assertion, the primary knowledge base is insufficient to verify it.","['https://pubmed.ncbi.nlm.nih.gov/36652553/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7614436/']"
"The first fatty acid synthase (FAS) inhibitor, TVB-2640, is in clinical trials for cancer.","TVB-2640, the first fatty acid synthase (FAS) inhibitor, is in clinical trials for cancer.",TVB-2640 is a fatty acid synthase inhibitor in clinical trials for cancer. The drug is being tested in combination with bevacizumab for relapsed high-grade astrocytoma. It shows promise in targeting lipid metabolism in breast cancer.,"1. Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab ... - https://pubmed.ncbi.nlm.nih.gov/37093199/
2. Clinical significance of lipid pathway-targeted therapy in breast cancer - https://pmc.ncbi.nlm.nih.gov/articles/PMC11743736/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS discuss dietary compounds and the effects of smoking on cancer, but contain no information regarding TVB-2640, fatty acid synthase (FAS) inhibitors, or their clinical trial status. While the TAVILY_SUMMARY supports that TVB-2640 is a FAS inhibitor in clinical trials, it does not confirm it is the 'first', and the primary knowledge base is insufficient to verify the assertion.","['https://pubmed.ncbi.nlm.nih.gov/37093199/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11743736/']"
"Markers such as cell type, oncogene mutations, expression/activity of lipid synthesis enzymes, and metabolic profiles can be used to predict cancer cell sensitivity to lipid synthesis inhibition.","Cell type, oncogene mutations, lipid synthesis enzyme expression/activity, and metabolic profiles can predict cancer cell sensitivity to lipid synthesis inhibition.","Cell type, oncogene mutations, lipid synthesis enzyme activity, and metabolic profiles predict cancer cell sensitivity to lipid synthesis inhibition. No single marker is definitive, but combinations are useful. FAS inhibitors show varied effectiveness based on these markers.","1. The Heterogeneity of Lipid Metabolism in Cancer - NCBI - https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/
2. Lipid Metabolism and Cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC9224822/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS discuss DNA polymerases, translesion DNA synthesis, and DNA repair, but contain no information regarding cell type, oncogene mutations, lipid synthesis enzymes, metabolic profiles, or their ability to predict cancer cell sensitivity to lipid synthesis inhibition. While the TAVILY_SUMMARY directly supports the assertion, the primary knowledge base is insufficient to verify it.","['https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9224822/']"
"The fact that lipoprotein supplementation can override DNLS inhibition emphasizes the importance of nutrient availability and, again, the role of exogenous lipid uptake.",Lipoprotein supplementation overriding DNLS inhibition emphasizes the importance of nutrient availability and exogenous lipid uptake.,"Lipoprotein supplementation can bypass DNLS inhibition, highlighting the importance of nutrient availability and exogenous lipid uptake. This suggests that external lipids can substitute for endogenous sources, impacting cancer cell metabolism.","1. The Heterogeneity of Lipid Metabolism in Cancer - NCBI - https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/
2. Lipid metabolism in sickness and in health: emerging regulators of ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8620413/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS explicitly state 'No relevant information found in knowledge base.' While the TAVILY_SUMMARY directly supports the assertion, the primary knowledge base is insufficient to verify it.","['https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8620413/']"
The availability of glucose for glucose-dependent lipogenesis is also important for cancer cell sensitivity to ACLY inhibitors.,Glucose availability for glucose-dependent lipogenesis influences cancer cell sensitivity to ACLY inhibitors.,"Glucose availability is crucial for cancer cell sensitivity to ACLY inhibitors. ACLY converts glucose into acetyl-CoA, which fuels fatty acid synthesis. ACLY inhibitors are more effective in glucose-dependent cancer cells.","1. Exploring the Role of ATP-Citrate Lyase in the Immune System - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7930476/
2. Metabolic reprogramming in cancer: Mechanisms and therapeutics - https://pmc.ncbi.nlm.nih.gov/articles/PMC10041388/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS discuss DNA repair assays and mutagen sensitivity, but contain no information regarding glucose availability, glucose-dependent lipogenesis, ACLY inhibitors, or cancer cell sensitivity to them. While the TAVILY_SUMMARY directly supports the assertion, the primary knowledge base is insufficient to verify it.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC7930476/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10041388/']"
Low-glucose environments result in cancer cells that are less susceptible to ACLY inhibition because cancer cells can use acetate instead of citrate to produce acetyl-CoA for DNLS.,"In low-glucose environments, cancer cells are less susceptible to ACLY inhibition as they can use acetate instead of citrate for acetyl-CoA production in DNLS.",Low-glucose environments make cancer cells less sensitive to ACLY inhibition because they can use acetate to produce acetyl-CoA instead of citrate. Acetyl-CoA is crucial for fatty acid synthesis and histone acetylation. Cancer cells adapt by alternative metabolic pathways.,"1. The Heterogeneity of Lipid Metabolism in Cancer - NCBI - https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/
2. Metabolic Strategies for Inhibiting Cancer Development - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8321873/",Flagged for Review,"The provided KNOWLEDGE_BASE_EXCERPTS discuss apoptosis, nAChRs, and AKT signaling, but contain no information regarding low-glucose environments, ACLY inhibition, acetate, citrate, acetyl-CoA production, or DNLS. While the TAVILY_SUMMARY directly supports the assertion, the primary knowledge base is insufficient to verify it.","['https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch3/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8321873/']"
Elgogary et al. present another case of spatial metabolic heterogeneity.,Elgogary et al. reported spatial metabolic heterogeneity.,"Elgogary et al. demonstrated spatial metabolic heterogeneity in pancreatic cancer, targeting it with combination therapy. Metabolic heterogeneity complicates cancer treatment. Spatial metabolic differences within tumors affect treatment efficacy.","1. Pancreatic Cancer: Advances and Challenges - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC10182830/
2. The Heterogeneity of Breast Cancer Metabolism - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK573680/",Correct,"The TAVILY_SUMMARY explicitly states that 'Elgogary et al. demonstrated spatial metabolic heterogeneity in pancreatic cancer'. The provided KNOWLEDGE_BASE_EXCERPTS do not contain information about Elgogary et al. or specific spatial metabolic heterogeneity in pancreatic cancer, but the TAVILY_SUMMARY directly supports the assertion.",[]
"Pancreatic tumors were targeted by bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES), a glutaminase 1 (GLS1) inhibitor, which was encapsulated in a nanoparticle to enhance drug delivery.","Pancreatic tumors were targeted by BPTES, a GLS1 inhibitor, encapsulated in nanoparticles for enhanced drug delivery.","Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) targets pancreatic tumors by inhibiting glutaminase. It is encapsulated in nanoparticles for better delivery. This method shows improved efficacy and reduced side effects.","1. Combination therapy with BPTES nanoparticles and metformin ... - https://pubmed.ncbi.nlm.nih.gov/27559084/
2. Mechanism by which a recently discovered allosteric inhibitor blocks ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4299208/",Correct,"The TAVILY_SUMMARY confirms that 'Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) targets pancreatic tumors by inhibiting glutaminase. It is encapsulated in nanoparticles for better delivery.' This is further supported by the RELEVANT_DOCS_LIST mentioning 'Combination therapy with BPTES nanoparticles' and BPTES as an 'allosteric inhibitor'.","['https://pubmed.ncbi.nlm.nih.gov/27559084/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4299208/']"
"The drug decreased tumor sizes, but metabolomics analysis revealed that surviving tumors relied on glycolysis and glycogen synthesis instead.","BPTES decreased tumor sizes, but surviving tumors shifted reliance to glycolysis and glycogen synthesis.","The drug reduced tumor size, but surviving tumors adapted by relying on glycolysis and glycogen synthesis. This shift indicates a metabolic reprogramming to sustain energy needs. Glycolysis allows cells to produce energy from glucose even when oxygen is limited.","1. Glycolysis, tumor metabolism, cancer growth and dissemination. A ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC4303887/
2. Metabolomics in Cancer Research and Emerging Applications in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8298088/",Correct,"The TAVILY_SUMMARY directly states that 'The drug reduced tumor size, but surviving tumors adapted by relying on glycolysis and glycogen synthesis.' The KNOWLEDGE_BASE_EXCERPTS and RELEVANT_DOCS_LIST do not contain specific information about BPTES or this particular metabolic shift.",[]
"Thus, further combination therapy of BPTES and metformin, a drug frequently used to treat diabetes by blocking glucose synthesis, further reduced tumor size.",Combination therapy of BPTES and metformin (glucose synthesis blocker for diabetes) further reduced tumor size.,"Combination therapy of BPTES and metformin effectively reduces tumor size by targeting both glutamine and glucose metabolism. Metformin inhibits glycolysis, while BPTES targets glutamine metabolism. This dual approach shows better results than monotherapy.","1. Glutamine Metabolism in Cancer - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK573682/
2. The beneficial effects of metformin on cancer prevention and therapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC6497052/",Flagged for Review,"The TAVILY_SUMMARY confirms that 'Combination therapy of BPTES and metformin effectively reduces tumor size'. However, the assertion describes metformin as a 'glucose synthesis blocker', while the TAVILY_SUMMARY states 'Metformin inhibits glycolysis'. Glycolysis is the breakdown of glucose, whereas glucose synthesis (gluconeogenesis) is a different metabolic process. This specific detail about metformin's mechanism is imprecise in the assertion.","['https://pubmed.ncbi.nlm.nih.gov/27559084/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6497052/']"
Metabolic cross talk between CAFs and cancer can be a metabolic target for cancer therapy.,Metabolic cross-talk between CAFs and cancer cells is a potential metabolic target for cancer therapy.,"Targeting metabolic crosstalk between cancer cells and cancer-associated fibroblasts can be a promising cancer therapy. Key targets include glycolysis, glutaminolysis, ketone bodies, and fatty acid metabolism. Treatments targeting these pathways are under investigation.","1. Targeting Metabolic Cross Talk Between Cancer Cells and ... - NCBI - https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch15/
2. Metabolic reprogramming of cancer-associated fibroblasts and its ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/",Correct,"The TAVILY_SUMMARY explicitly states that 'Targeting metabolic crosstalk between cancer cells and cancer-associated fibroblasts can be a promising cancer therapy.' This is directly supported by the RELEVANT_DOCS_LIST, which includes a document titled 'Targeting Metabolic Cross Talk Between Cancer Cells and...'.","['https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch15/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8343997/']"
"The reverse Warburg effects can be targeted via disruption of the \""lactate shuttle\"" by MCT1/MCT 4 inhibitors.","Reverse Warburg effects can be targeted by disrupting the \""lactate shuttle\"" with MCT1/MCT4 inhibitors.","The reverse Warburg effect can be targeted by inhibiting MCT1/MCT4 to disrupt the lactate shuttle. MCT inhibitors block lactate transport, potentially hindering cancer metabolism. This approach shows promise in cancer treatment.","1. Exploring monocarboxylate transporter inhibition for cancer treatment - https://pmc.ncbi.nlm.nih.gov/articles/PMC10918235/
2. The role of MCT1 in tumor progression and targeted therapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC12222217/",Correct,"The TAVILY_SUMMARY directly supports the assertion: 'The reverse Warburg effect can be targeted by inhibiting MCT1/MCT4 to disrupt the lactate shuttle.' This is further corroborated by the RELEVANT_DOCS_LIST, which includes articles on 'Exploring monocarboxylate transporter inhibition for cancer treatment' and 'The role of MCT1 in tumor progression and targeted therapy'.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10918235/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12222217/']"
"Metformin can be used to inhibit glycolysis and block the function of CAFs, which promote cancer cell growth.","Metformin inhibits glycolysis and blocks CAF function, which promotes cancer cell growth.","Metformin inhibits glycolysis and blocks cancer-associated fibroblasts, reducing tumor growth. It restores Cav-1 expression and inhibits autophagy. Metformin is tested in cancer therapy to improve treatment outcomes.","1. Metabolic Reprogramming of Cancer Associated Fibroblasts - https://pmc.ncbi.nlm.nih.gov/articles/PMC6008683/
2. Cancer associated fibroblasts in cancer development and therapy - https://pmc.ncbi.nlm.nih.gov/articles/PMC11954198/",Correct,"The TAVILY_SUMMARY states that 'Metformin inhibits glycolysis and blocks cancer-associated fibroblasts, reducing tumor growth.' The RELEVANT_DOCS_LIST also discusses 'Metabolic Reprogramming of Cancer Associated Fibroblasts' and 'Cancer associated fibroblasts in cancer development and therapy', supporting the role of CAFs.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6008683/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11954198/']"
Blocking the glutamine uptake of cancer cells from CAFs is a strategy in targeting glutaminolysis.,Blocking cancer cell glutamine uptake from CAFs is a strategy for targeting glutaminolysis.,"Blocking glutamine uptake from cancer-associated fibroblasts targets glutaminolysis, a key metabolic pathway in cancer cells. This strategy disrupts cancer cell growth and survival. Combining this with other metabolic inhibitors can enhance effectiveness.","1. Targeting Metabolic Cross Talk Between Cancer Cells and ... - NCBI - https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch15/
2. Targeting glutamine metabolism as a therapeutic strategy for cancer - https://pmc.ncbi.nlm.nih.gov/articles/PMC10167356/",Correct,"The TAVILY_SUMMARY directly supports the assertion: 'Blocking glutamine uptake from cancer-associated fibroblasts targets glutaminolysis, a key metabolic pathway in cancer cells.' The RELEVANT_DOCS_LIST also includes 'Targeting Metabolic Cross Talk Between Cancer Cells and...' and 'Targeting glutamine metabolism as a therapeutic strategy for cancer'.","['https://www.ncbi.nlm.nih.gov/books/n/spr9783030657680/ch15/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10167356/']"
"The response to cytotoxic drugs often depends on the metabolic state of the cancer cells, and these cells rewire the metabolism of anticancer drugs.","Cancer cell metabolic state influences response to cytotoxic drugs, and cells rewire anticancer drug metabolism.","Cancer cells often adapt their metabolism to resist chemotherapy, significantly influencing drug response. Metabolic rewiring, including changes in redox buffering and glycolysis, helps cancer cells survive treatment. This metabolic adaptation is a key mechanism of resistance.","1. The Influence of Metabolism on Drug Response in Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6230982/
2. Metabolic Plasticity in Chemotherapy Resistance - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC7068907/",Correct,"The TAVILY_SUMMARY explicitly states that 'Cancer cells often adapt their metabolism to resist chemotherapy, significantly influencing drug response. Metabolic rewiring... helps cancer cells survive treatment.' This is further supported by the RELEVANT_DOCS_LIST, which includes articles on 'The Influence of Metabolism on Drug Response in Cancer' and 'Metabolic Plasticity in Chemotherapy Resistance'.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC6230982/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7068907/']"
Metabolic alterations can be influenced by various factors such as oncogenes or tumor suppressor genes and the tumor microenvironment.,"Metabolic alterations are influenced by oncogenes, tumor suppressor genes, and the tumor microenvironment.",Oncogenes and tumor suppressor genes drive metabolic changes in cancer. These genetic alterations reprogram metabolism to meet cancer cell needs. The tumor microenvironment further influences these metabolic shifts.,"1. Oncogenes and tumor suppressor genes: functions and roles in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11141506/
2. Oncogene-Driven Metabolic Alterations in Cancer - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5746037/",Correct,"The TAVILY_SUMMARY directly supports the assertion: 'Oncogenes and tumor suppressor genes drive metabolic changes in cancer... The tumor microenvironment further influences these metabolic shifts.' The RELEVANT_DOCS_LIST also includes 'Oncogenes and tumor suppressor genes: functions and roles in...' and 'Oncogene-Driven Metabolic Alterations in Cancer'. The KNOWLEDGE_BASE_EXCERPTS discuss the roles of oncogenes and tumor suppressor genes in cancer, providing foundational context.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11141506/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5746037/']"
"Downstream of survival signaling pathways, the Warburg effect, which refers to the increased rate of glycolysis in tumorigenic cells, can be observed even in conditions of normal oxygen levels.","The Warburg effect, increased glycolysis in tumorigenic cells, is observed downstream of survival signaling pathways even in normal oxygen.",The Warburg effect enhances cancer cell survival by increasing glycolysis even with normal oxygen levels. It provides energy and metabolic intermediates for rapid cell growth. This effect is crucial for tumorigenic cells to thrive despite nutrient restrictions.,"1. The Warburg Effect: How Does it Benefit Cancer Cells? - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4783224/
2. Metabolic reprogramming ensures cancer cell survival despite ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5733498/",Correct,"The TAVILY_SUMMARY explicitly states that the Warburg effect enhances cancer cell survival by increasing glycolysis even with normal oxygen levels, and that it is crucial for tumorigenic cells. While the KNOWLEDGE_BASE_EXCERPTS discuss various survival signaling pathways and their downstream effects, they do not explicitly link them to the Warburg effect. However, the TAVILY_SUMMARY provides direct confirmation.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4783224/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5733498/']"
"In c-Myc-driven HCC, glucose catabolism through glycolysis is elevated via the activation of pyruvate kinase.","In c-Myc-driven HCC, glucose catabolism via glycolysis is elevated through pyruvate kinase activation.","In c-Myc-driven HCC, glycolysis is elevated via PKM2 activation, enhancing pyruvate formation and fueling tumor metabolism. PKM2 also drives HIF-1α activation, influencing immune response. This reprogramming favors anaerobic glycolysis over oxidative phosphorylation.","1. Metabolic reprogramming in hepatocellular carcinoma - https://pmc.ncbi.nlm.nih.gov/articles/PMC11958682/
2. Metabolic reprogramming in hepatocellular carcinoma: mechanisms ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12075234/",Correct,"The TAVILY_SUMMARY directly confirms that in c-Myc-driven HCC, glycolysis is elevated via PKM2 activation, which enhances pyruvate formation and fuels tumor metabolism. The KNOWLEDGE_BASE_EXCERPTS discuss the role of MYC in cancer but do not specifically mention its link to glycolysis or pyruvate kinase activation in HCC.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11958682/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12075234/']"
"Inhibition of glycolysis and increase in oxidative phosphorylation can re-sensitize HCC cells to chemotherapeutics such as sorafenib, cisplatin, and isoliensinine.","Inhibiting glycolysis and increasing oxidative phosphorylation can re-sensitize HCC cells to chemotherapeutics like sorafenib, cisplatin, and isoliensinine.","Inhibition of glycolysis and increase in oxidative phosphorylation can re-sensitize HCC cells to chemotherapeutics. Sorafenib, cisplatin, and isoliensinine show improved efficacy under these conditions. This approach is promising for overcoming drug resistance in HCC.","1. Multifaceted roles of aerobic glycolysis and oxidative ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9899054/
2. Dauricine: Review of Pharmacological Activity - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC11444063/",Correct,"The TAVILY_SUMMARY explicitly states that inhibition of glycolysis and an increase in oxidative phosphorylation can re-sensitize HCC cells to chemotherapeutics, including sorafenib, cisplatin, and isoliensinine, showing improved efficacy under these conditions. The KNOWLEDGE_BASE_EXCERPTS do not contain this specific information.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9899054/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11444063/']"
Solid tumors are heterogeneous structures.,Solid tumors are heterogeneous structures.,"Solid tumors are complex and diverse, consisting of multiple subclones and specialized cell types. Their heterogeneity complicates treatment. Understanding these differences is key for effective therapy.","1. Understanding tumor heterogeneity as functional compartments - https://pmc.ncbi.nlm.nih.gov/articles/PMC3118334/
2. Mechanisms and clinical implications of tumor heterogeneity and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6296823/",Correct,"The TAVILY_SUMMARY explicitly states that solid tumors are complex and diverse, consisting of multiple subclones and specialized cell types, and that their heterogeneity complicates treatment. This directly supports the assertion that solid tumors are heterogeneous structures. The RELEVANT_DOCS_LIST also includes titles directly addressing tumor heterogeneity.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3118334/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6296823/']"
"The tumor microenvironment is composed of cancer and stromal cells embedded in extracellular matrix, sustained by aberrant vasculature.","The tumor microenvironment comprises cancer and stromal cells in extracellular matrix, sustained by aberrant vasculature.","The tumor microenvironment includes cancer cells, stromal cells, immune cells, and extracellular matrix. Aberrant vasculature supports this complex environment. It plays a crucial role in tumor progression and therapy.","1. The cellular composition of the tumor microenvironment is an ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10937353/
2. Tumor Microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/",Correct,"The TAVILY_SUMMARY explicitly states that the tumor microenvironment includes cancer cells, stromal cells, immune cells, and extracellular matrix, and that aberrant vasculature supports this complex environment. This directly confirms the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10937353/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8194051/']"
"Tumor hypoperfusion, secondary to the hyperpermeability of the aberrant vasculature, along with low oxygen, depleted nutrition, low pH, and high interstitial pressure can cause chemoresistance.","Tumor hypoperfusion (due to aberrant vasculature hyperpermeability), low oxygen, depleted nutrition, low pH, and high interstitial pressure can cause chemoresistance.","Tumor hypoperfusion due to hyperpermeable aberrant vasculature, along with low oxygen, depleted nutrition, low pH, and high interstitial pressure, leads to chemoresistance. This environment favors tumor progression and therapy resistance.","1. Multidrug Resistance in Hepatocellular Carcinoma - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK549189/
2. Visualizing vasculature and its response to therapy in the tumor ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10614675/",Correct,"The TAVILY_SUMMARY directly confirms that tumor hypoperfusion (due to hyperpermeable aberrant vasculature), low oxygen, depleted nutrition, low pH, and high interstitial pressure lead to chemoresistance. The KNOWLEDGE_BASE_EXCERPTS do not contain this specific information.","['https://www.ncbi.nlm.nih.gov/books/NBK549189/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10614675/']"
"Compared to normal cells, cancer cells exhibit higher glucose metabolism rates and preferentially utilize glycolysis over oxidative phosphorylation, especially in hypoxic conditions (Warburg effect).","Cancer cells exhibit higher glucose metabolism rates and preferentially utilize glycolysis over oxidative phosphorylation, especially in hypoxic conditions (Warburg effect), compared to normal cells.","Cancer cells have higher glucose metabolism rates and prefer glycolysis over oxidative phosphorylation, especially in low-oxygen conditions (Warburg effect).","1. The Warburg Effect: How Does it Benefit Cancer Cells? - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4783224/
2. Energy metabolism of cancer: Glycolysis versus oxidative ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3506713/",Correct,"The TAVILY_SUMMARY explicitly states that cancer cells have higher glucose metabolism rates and prefer glycolysis over oxidative phosphorylation, especially in low-oxygen conditions (Warburg effect). This directly supports the assertion. The KNOWLEDGE_BASE_EXCERPTS do not contain this specific information.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC4783224/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3506713/']"
"This process ultimately generates lactic acid, leading to intracellular acidification.","Increased glycolysis in cancer cells generates lactic acid, leading to intracellular acidification.","Glycolysis produces lactic acid, causing intracellular acidification. Lactic acid is a byproduct of anaerobic glucose metabolism. This process occurs during intense exercise.","1. Lactate metabolism in human health and disease - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9434547/
2. From metabolic byproduct to immune modulator: the role of lactate in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11625744/",Correct,"The TAVILY_SUMMARY explicitly states that glycolysis produces lactic acid, causing intracellular acidification. This directly supports the assertion. The KNOWLEDGE_BASE_EXCERPTS mention anaerobic respiration but do not specifically link increased glycolysis in cancer cells to lactic acid generation and intracellular acidification.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9434547/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11625744/']"
"As a result, cancer cells may express relatively more proton pumps in order to maintain intracellular pH homeostasis, rendering the extracellular environment highly acidic.","Cancer cells may express more proton pumps to maintain intracellular pH, rendering the extracellular environment highly acidic.","Cancer cells often express more proton pumps to maintain a slightly alkaline intracellular pH, creating an acidic extracellular environment. This acidity aids in extracellular matrix digestion and immune evasion. Proton extrusion mechanisms help cancer cells manage pH balance.","1. Cancer: fundamentals behind pH targeting and the double-edged ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC5074768/
2. Emerging Role of Extracellular pH in Tumor Microenvironment as a ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11592846/",Correct,"The TAVILY_SUMMARY explicitly states that cancer cells often express more proton pumps to maintain a slightly alkaline intracellular pH, thereby creating an acidic extracellular environment. This directly supports the assertion. The KNOWLEDGE_BASE_EXCERPTS do not contain this specific information.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5074768/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11592846/']"
There is heterogeneity in glucose metabolism across tumor types as well as within the tumor microenvironment.,Glucose metabolism exhibits heterogeneity across tumor types and within the tumor microenvironment.,Glucose metabolism varies widely among different tumor types and within the tumor microenvironment. Aerobic glycolysis differs across tumors and even within a single tumor. Metabolic heterogeneity is influenced by tumor cell type and the surrounding environment.,"1. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/
2. Mechanisms and implications of metabolic heterogeneity in cancer - https://pmc.ncbi.nlm.nih.gov/articles/PMC6730674/",Correct,"The TAVILY_SUMMARY explicitly states that glucose metabolism varies widely among different tumor types and within the tumor microenvironment, and that metabolic heterogeneity is influenced by tumor cell type and the surrounding environment. This directly supports the assertion. The KNOWLEDGE_BASE_EXCERPTS discuss heterogeneity in other contexts but not specifically for glucose metabolism.","['https://www.ncbi.nlm.nih.gov/books/NBK573693/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6730674/']"
Numerous therapies targeting glucose metabolism have been developed but have yet to show success in clinical trials.,Numerous therapies targeting glucose metabolism developed have not yet succeeded in clinical trials.,"Despite numerous therapies targeting glucose metabolism, clinical trials have not shown success. Examples include lonidamine and phosphofructokinase inhibitors. Ivosidenib shows promise but lacks conclusive results.","1. Targeting Glucose Metabolism Enzymes in Cancer Treatment - https://pmc.ncbi.nlm.nih.gov/articles/PMC9559313/
2. Glucose Metabolism in Cancer: The Warburg Effect and Beyond - https://www.ncbi.nlm.nih.gov/books/NBK573693/",Correct,"The TAVILY_SUMMARY explicitly states that 'Despite numerous therapies targeting glucose metabolism, clinical trials have not shown success. Examples include lonidamine and phosphofructokinase inhibitors. Ivosidenib shows promise but lacks conclusive results,' directly supporting the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9559313/', 'https://www.ncbi.nlm.nih.gov/books/NBK573693/']"
The tumor microenvironment influences the sensitivity of cancer cells to lipid synthesis inhibition.,The tumor microenvironment influences cancer cell sensitivity to lipid synthesis inhibition.,The tumor microenvironment affects cancer cells' sensitivity to lipid synthesis inhibition. Lipid metabolism influences immune response and cancer progression. Targeting lipid metabolism can enhance cancer treatment efficacy.,"1. The role of lipid metabolism in tumor immune microenvironment and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9510836/
2. Lipids in the Tumor Microenvironment: From Cancer Progression to ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC7674189/",Correct,The TAVILY_SUMMARY directly confirms that 'The tumor microenvironment affects cancer cells' sensitivity to lipid synthesis inhibition.' The relevant documents also highlight the role of lipids and lipid metabolism within the tumor microenvironment.,"['https://pmc.ncbi.nlm.nih.gov/articles/PMC9510836/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC7674189/']"
Natural products can also increase the sensitivity of HCC cells to anticancer drugs by regulating cellular metabolism.,Natural products can increase HCC cell sensitivity to anticancer drugs by regulating cellular metabolism.,"Natural products can enhance sensitivity of HCC cells to anticancer drugs by inhibiting glycolysis and reducing drug efflux proteins. Examples include chrysin, berberine, and emodin. These compounds target metabolic pathways to improve chemotherapy effectiveness.","1. Metabolic dysregulation and emerging therapeutical targets for ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8897153/
2. Targeting Drug Chemo-Resistance in Cancer Using Natural Products - https://pmc.ncbi.nlm.nih.gov/articles/PMC8533186/",Correct,"The TAVILY_SUMMARY explicitly states that 'Natural products can enhance sensitivity of HCC cells to anticancer drugs by inhibiting glycolysis and reducing drug efflux proteins. ... These compounds target metabolic pathways to improve chemotherapy effectiveness,' which directly supports the assertion.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8897153/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC8533186/']"
"Li and colleagues demonstrated that dauricine dose-dependently suppressed glucose glycolysis and increased oxidative phosphorylation by downregulating the expression of hexokinase 2 and pyruvate kinase M2, consequently increasing the sensitivities of HCC to cisplatin, sorafenib, and isoliensinine.","Li et al. demonstrated dauricine dose-dependently suppressed glucose glycolysis and increased oxidative phosphorylation by downregulating hexokinase 2 and pyruvate kinase M2, increasing HCC sensitivity to cisplatin, sorafenib, and isoliensinine.","Dauricine suppresses glycolysis and boosts oxidative phosphorylation in HCC, enhancing sensitivity to cisplatin, sorafenib, and isoliensinine by downregulating hexokinase 2 and pyruvate kinase M2. This mechanism re-sensitizes cancer cells to chemotherapeutics.","1. Multidrug Resistance in Hepatocellular Carcinoma - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK549189/
2. Dauricine: Review of Pharmacological Activity - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC11444063/",Correct,"The TAVILY_SUMMARY directly corroborates the assertion, stating that 'Dauricine suppresses glycolysis and boosts oxidative phosphorylation in HCC, enhancing sensitivity to cisplatin, sorafenib, and isoliensinine by downregulating hexokinase 2 and pyruvate kinase M2.'","['https://www.ncbi.nlm.nih.gov/books/NBK549189/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11444063/']"
"Experimental data show that natural products can reverse MDR via regulating drug efflux, drug metabolism, and apoptotic pathways in cancer cells.","Experimental data show natural products reverse MDR by regulating drug efflux, drug metabolism, and apoptotic pathways in cancer cells.","Natural products reverse multidrug resistance in cancer cells by regulating drug efflux, metabolism, and apoptosis. Key compounds include flavonoids, tannins, alkaloids, and terpenoids. They induce apoptosis in cancer cells.","1. Natural Products for Cancer Therapy: A Review of Their Mechanism ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8933079/
2. Herbal Medicine as Inducers of Apoptosis in Cancer Treatment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC4213780/",Correct,"The TAVILY_SUMMARY directly confirms the assertion: 'Natural products reverse multidrug resistance in cancer cells by regulating drug efflux, metabolism, and apoptosis.' The relevant documents also support the role of natural products in cancer therapy and apoptosis.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8933079/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4213780/']"
"Despite a better understanding of the mechanisms of drug resistance, and the experimental approaches that have been taken to overcome drug resistance over the decades, clinical utility of these approaches has not come to fruition.","Despite understanding drug resistance mechanisms and experimental approaches, clinical utility of these approaches has not materialized.","Despite decades of research, drug resistance mechanisms remain complex, and clinical applications of new strategies have been limited. Many experimental approaches have not translated into effective treatments. Resistance involves multiple mechanisms, including gene mutations and efflux pumps.","1. The Different Mechanisms of Cancer Drug Resistance: A Brief Review - https://pmc.ncbi.nlm.nih.gov/articles/PMC5651054/
2. Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10675245/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Despite decades of research, drug resistance mechanisms remain complex, and clinical applications of new strategies have been limited. Many experimental approaches have not translated into effective treatments,' indicating that clinical utility has not materialized.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5651054/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10675245/']"
"Simply put, what makes cancer one of the deadliest diseases is its ability to change and adapt.",Cancer's ability to change and adapt contributes to its deadliness.,"Cancer's lethality stems from its ability to rapidly evolve and adapt to survive harsh conditions, allowing it to evade treatments and spread throughout the body. Its genetic instability enables continuous mutation and survival in hostile environments. This adaptability makes cancer difficult to cure.","1. Cancer as a Microevolutionary Process - Molecular Biology of the Cell - https://www.ncbi.nlm.nih.gov/books/NBK26891/
2. The systemic evolutionary theory of the origin of cancer (SETOC) - https://pmc.ncbi.nlm.nih.gov/articles/PMC11730465/",Correct,"The TAVILY_SUMMARY explicitly states that 'Cancer's lethality stems from its ability to rapidly evolve and adapt to survive harsh conditions, allowing it to evade treatments and spread throughout the body. ... This adaptability makes cancer difficult to cure,' directly supporting the assertion.","['https://www.ncbi.nlm.nih.gov/books/NBK26891/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11730465/']"
"Cancer cells' rapid evolution, coupled with their irrepressible ability to divide, gives most of them the advantage over our immune systems.",Cancer cells' rapid evolution and irrepressible division give them an advantage over immune systems.,"Cancer cells rapidly evolve and evade immune detection, creating a tumor microenvironment that hinders immune elimination. Their short-term adaptations are temporary, unlike our long-term cultural evolution. This gives humans a strategic advantage.","1. The Evasion Mechanisms of Cancer Immunity and Drug Intervention ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9171538/
2. Short‐ and long‐term evolution in our arms race with cancer - https://pmc.ncbi.nlm.nih.gov/articles/PMC5999210/",Correct,"The TAVILY_SUMMARY states that 'Cancer cells rapidly evolve and evade immune detection, creating a tumor microenvironment that hinders immune elimination,' which supports the idea of cancer cells gaining an advantage over immune systems through evolution. The irrepressible division is a fundamental characteristic contributing to this advantage.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9171538/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5999210/']"
"This chapter sheds light on one of cancer's most impactful attributes: its heterogeneity and, more specifically, the intratumoral heterogeneity of cancer metabolism.",Intratumoral heterogeneity of cancer metabolism is an impactful attribute of cancer.,Cancer's intratumoral heterogeneity significantly impacts its adaptability and treatment. This metabolic diversity complicates cancer progression and therapy. Tailored therapies targeting specific metabolic pathways are emerging.,"1. The Intratumoral Heterogeneity of Cancer Metabolism - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK573672/
2. The Intratumoral Heterogeneity of Cancer Metabolism - PubMed - https://pubmed.ncbi.nlm.nih.gov/34014541/",Correct,The TAVILY_SUMMARY directly confirms that 'Cancer's intratumoral heterogeneity significantly impacts its adaptability and treatment. This metabolic diversity complicates cancer progression and therapy.' The relevant documents also explicitly address this topic.,"['https://www.ncbi.nlm.nih.gov/books/NBK573672/', 'https://pubmed.ncbi.nlm.nih.gov/34014541/']"
Cancer metabolism represents a complex and dynamic aspect of tumor biology that extends far beyond the classical Warburg effect.,"Cancer metabolism is a complex, dynamic aspect of tumor biology extending beyond the classical Warburg effect.","Cancer metabolism involves complex metabolic reprogramming beyond the Warburg effect, driven by genetic and epigenetic changes, and is crucial for tumor growth and survival. Metabolic adaptation is key for cancer cells to thrive in harsh tumor environments. Research targets these altered metabolic pathways for cancer treatment.","1. Cancer metabolism and carcinogenesis - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC10826200/
2. Metabolic changes in cancer: beyond the Warburg effect - PubMed - https://pubmed.ncbi.nlm.nih.gov/23257292/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that 'Cancer metabolism involves complex metabolic reprogramming beyond the Warburg effect, driven by genetic and epigenetic changes, and is crucial for tumor growth and survival.' The relevant documents also have titles that confirm this concept.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC10826200/', 'https://pubmed.ncbi.nlm.nih.gov/23257292/']"
"The metabolic reprogramming observed in cancer cells serves multiple functions: supporting elevated energy demands, providing building blocks for biosynthesis, maintaining redox balance, and facilitating adaptation to the challenging tumor microenvironment.","Metabolic reprogramming in cancer cells supports elevated energy demands, provides biosynthetic building blocks, maintains redox balance, and facilitates TME adaptation.","Cancer cells reprogram metabolism to boost energy, synthesize building blocks, maintain redox balance, and adapt to the tumor environment. Key metabolic pathways include glycolysis, glutaminolysis, and the pentose phosphate pathway. This adaptation supports rapid growth and resistance to treatments.","1. Cancer metabolic reprogramming: importance, main features, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3969803/
2. The significant role of amino acid metabolic reprogramming in cancer - https://pmc.ncbi.nlm.nih.gov/articles/PMC11285422/",Correct,"The TAVILY_SUMMARY explicitly states that cancer cells reprogram metabolism to boost energy, synthesize building blocks, maintain redox balance, and adapt to the tumor environment, directly supporting the assertion. The relevant documents also indicate coverage of cancer metabolic reprogramming.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3969803/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11285422/']"
"The discovery that cancer metabolism involves not only the cancer cells themselves but also the supporting stromal cells, particularly cancer-associated fibroblasts, has revolutionized our understanding of tumor biology.","Cancer metabolism involves cancer cells and supporting stromal cells (CAFs), revolutionizing tumor biology understanding.","Cancer metabolism involves cancer cells and supporting stromal cells, especially cancer-associated fibroblasts, which significantly impact tumor progression and metastasis. These fibroblasts create metabolic gradients within tumors, influencing growth and survival.","1. PubMed Central Cancer associated fibroblasts: An essential role in the tumor microenvironment - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5588104/
2. Cancer metabolism drives a stromal regenerative response - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC6692899/",Correct,"The TAVILY_SUMMARY confirms that cancer metabolism involves cancer cells and supporting stromal cells, particularly cancer-associated fibroblasts (CAFs), and that this significantly impacts tumor progression. The relevant documents also highlight the essential role of CAFs in the tumor microenvironment and their metabolic contributions.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5588104/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6692899/']"
The metabolic cross-talk between these different cell types creates a complex ecosystem that supports tumor growth and progression.,Metabolic cross-talk between different cell types creates a complex ecosystem supporting tumor growth and progression.,"Metabolic cross-talk among tumor cells, immune cells, and stromal cells supports tumor growth and progression. Tumor-associated fibroblasts (CAFs) often engage in a 'reverse Warburg effect', providing metabolites to fuel cancer cells. This metabolic interplay creates a pro-tumorigenic environment.","1. Metabolites and the tumor microenvironment: from cellular ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC8097259/
2. Tumor microenvironment as a complex milieu driving cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12033186/",Correct,"The TAVILY_SUMMARY directly supports the assertion, stating that metabolic cross-talk among tumor cells, immune cells, and stromal cells creates a complex ecosystem that supports tumor growth and progression. The relevant documents also discuss metabolites and the tumor microenvironment.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC8097259/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC12033186/']"
"1. The Warburg effect remains relevant but represents only one aspect of cancer metabolism, with significant heterogeneity both between and within tumors.","The Warburg effect is relevant but is one aspect of cancer metabolism, with significant heterogeneity between and within tumors.","The Warburg effect remains relevant but cancer cells exhibit diverse metabolic pathways beyond aerobic glycolysis, with significant heterogeneity within and between tumors. Cancer stem cells contribute to this metabolic diversity.","1. The Intratumoral Heterogeneity of Cancer Metabolism - NCBI - https://www.ncbi.nlm.nih.gov/books/NBK573672/
2. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K - https://pubmed.ncbi.nlm.nih.gov/25689954/",Correct,"The TAVILY_SUMMARY explicitly states that the Warburg effect remains relevant but that cancer cells exhibit diverse metabolic pathways and significant heterogeneity within and between tumors, directly supporting the assertion. The relevant documents also address intratumoral heterogeneity of cancer metabolism.","['https://www.ncbi.nlm.nih.gov/books/NBK573672/', 'https://pubmed.ncbi.nlm.nih.gov/25689954/']"
"2. Mitochondria retain important functions in cancer cells, contributing to both energy production and biosynthetic processes essential for tumor growth.","Mitochondria retain important functions in cancer cells, contributing to energy production and biosynthetic processes essential for tumor growth.","Mitochondria in cancer cells support energy production and biosynthetic processes, enhancing tumor growth. They also influence cellular invasiveness and the reverse Warburg effect. Mitochondrial mutations alter bioenergetic states without fully inactivating them.","1. An Overview: The Diversified Role of Mitochondria in Cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC9910000/
2. Mitochondria and cancer - PMC - PubMed Central - https://pmc.ncbi.nlm.nih.gov/articles/PMC4371788/",Correct,"The TAVILY_SUMMARY confirms that mitochondria in cancer cells support energy production and biosynthetic processes, which are essential for tumor growth. The relevant documents also discuss the diversified role of mitochondria in cancer.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC9910000/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC4371788/']"
"3. Lipid and amino acid metabolism are extensively reprogrammed in cancer, with particular importance for glutamine metabolism and fatty acid synthesis.","Lipid and amino acid metabolism are extensively reprogrammed in cancer, with particular importance for glutamine metabolism and fatty acid synthesis.","Cancer cells extensively reprogram lipid and amino acid metabolism, especially glutamine, to fuel rapid growth and proliferation. Glutamine is crucial for energy and biosynthesis, while fatty acid synthesis increases to support cell membrane and signaling needs. This metabolic reprogramming is key to cancer survival and resistance.","1. Cancer metabolic reprogramming: importance, main features, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3969803/
2. Reprogramming of glucose, fatty acid and amino acid metabolism ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11108301/",Correct,"The TAVILY_SUMMARY states that cancer cells extensively reprogram lipid and amino acid metabolism, with glutamine and fatty acid synthesis being particularly important for rapid growth and proliferation. The relevant documents also cover cancer metabolic reprogramming, including amino acid and fatty acid metabolism.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3969803/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11108301/']"
"4. The tumor microenvironment plays a crucial role in cancer metabolism, with cancer-associated fibroblasts acting as metabolic partners that support cancer cell growth.","The tumor microenvironment plays a crucial role in cancer metabolism, with CAFs acting as metabolic partners supporting cancer cell growth.",Cancer-associated fibroblasts support cancer cell growth by altering metabolism in the tumor microenvironment. They create an acidic and hypoxic environment that influences cancer cell metabolism. This interaction is crucial for tumor progression.,"1. Tumor Microenvironment and Metabolism - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5751330/
2. Cancer-associated fibroblasts: from basic science to anticancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC10394065/",Correct,"The TAVILY_SUMMARY explicitly states that cancer-associated fibroblasts (CAFs) support cancer cell growth by altering metabolism in the tumor microenvironment, confirming their role as metabolic partners. The relevant documents also discuss the tumor microenvironment and CAFs.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC5751330/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC10394065/']"
"5. Therapeutic targeting of cancer metabolism shows promise but faces challenges related to metabolic flexibility, drug resistance, and the need for personalized approaches.","Therapeutic targeting of cancer metabolism shows promise but faces challenges from metabolic flexibility, drug resistance, and the need for personalized approaches.","Targeting cancer metabolism is promising but faces challenges due to metabolic flexibility, drug resistance, and the need for personalized treatments. Innovative strategies and precision medicine are essential to address these issues effectively.","1. Emerging Therapeutic Strategies to Overcome Drug Resistance in ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11240358/
2. The growing role of precision and personalized medicine for cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC6352312/",Correct,"The TAVILY_SUMMARY directly supports the assertion, listing metabolic flexibility, drug resistance, and the need for personalized treatments as challenges for therapeutic targeting of cancer metabolism. The relevant documents also address overcoming drug resistance and the role of personalized medicine.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC11240358/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6352312/']"
"Despite significant advances in understanding cancer metabolism, successful clinical translation remains challenging.","Despite advances in understanding cancer metabolism, successful clinical translation remains challenging.","Despite significant advances in cancer metabolism research, translating these findings into effective clinical therapies remains challenging due to tumor heterogeneity and inter-patient variability. Further research is needed to refine treatment strategies and improve patient outcomes.","1. Exploiting tumor metabolism: challenges for clinical translation - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3754281/
2. Overcoming Challenges in Cancer Care: A Focus on Emerging ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC11672937/",Correct,"The TAVILY_SUMMARY explicitly states that despite advances in cancer metabolism research, successful clinical translation into effective therapies remains challenging. The relevant documents also discuss challenges for clinical translation in exploiting tumor metabolism.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC3754281/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11672937/']"
"The metabolic flexibility of cancer cells, the complexity of the tumor microenvironment, and the heterogeneity within and between tumors all contribute to the difficulty in developing effective metabolic therapies.","Cancer cell metabolic flexibility, TME complexity, and tumor heterogeneity contribute to difficulty in developing effective metabolic therapies.","Cancer cells' metabolic flexibility, tumor microenvironment complexity, and tumor heterogeneity make metabolic therapies challenging. These factors complicate targeting cancer metabolism effectively.","1. Tumor Microenvironment: A Complex Landscape of Cancer ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC12066109/
2. Cancer metabolic reprogramming: importance, main features, and ... - https://pmc.ncbi.nlm.nih.gov/articles/PMC3969803/",Correct,"The TAVILY_SUMMARY directly supports the assertion, identifying cancer cell metabolic flexibility, tumor microenvironment complexity, and tumor heterogeneity as factors that make developing effective metabolic therapies challenging. The relevant documents also cover the tumor microenvironment and cancer metabolic reprogramming.","['https://pmc.ncbi.nlm.nih.gov/articles/PMC12066109/', 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3969803/']"
